ࡱ> y{tuvwx ԜbjbjVV U<<W }}}@A$}0pe. " !!!ooooooorto9)!!))o o"000)  j0)o002)f6Yj _w}.Xg.jo<0pgnvu.vu\YjvuYj|!(#0F%<&7!!!oo0X!!!0p))))vu!!!!!!!!! : Running Head: BIOFEEDBACK TREATMENT FOR HEADACHE DISORDERS Biofeedback Treatment for Headache Disorders: A Comprehensive Efficacy Review Yvonne Nestoriuc1,3, Alexandra Martin2, Winfried Rief3 & Frank Andrasik4 1 Brigham and Womens Hospital, Department of Psychiatry, Harvard Medical School, Boston 2 Department of Psychosomatic Medicine and Psychotherapy, University of Erlangen-Nuernberg, Germany 3 Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany 4 Department of Psychology, University of West Florida Word count: 5054, Abstract: 200 words Total pages: 38 (incl. Appendix) Number of tables: 3, Number of figures: 2 Dr. Yvonne Nestoriuc (corresponding author) Brigham and Womens Hospital, Department of Psychiatry, Harvard Medical School 1620 Tretmont Street, Boston, MA, 02120 Phone: 617 732 5969, Email:  HYPERLINK "mailto:ynestoriuc@partners.org" ynestoriuc@partners.org Abstract The aim of the present review was to critically evaluate the documented evidence regarding the efficacy of biofeedback for the two most prevalent headache conditions migraine and tension-type headache. Drawing upon two recently published meta-analyses, data from 150 outcome studies, including randomized controlled trials as well as uncontrolled quasi-experimental designs, were screened. Of these, 94 studies were selected for inclusion according to predefined criteria. Meta-analytic integrations were carried out separately for the two conditions of interest. The main results were medium-to-large mean effect sizes for biofeedback in adult migraine and tension-type headache patients. Treatment effects remained stable over an average follow-up period of 14 months, both in completer and intention-to-treat analyses. Headache frequency was the primary outcome variable and showed the largest improvements. Further significant effects were shown for perceived self-efficacy, symptoms of anxiety and depression, and medication consumption. Reduced muscle tension in pain related areas was observed in electromyographic feedback for tension-type headache. Biofeedback was more effective than waiting list and headache monitoring conditions in all cases, while electromyographic feedback for tension-type headache showed additional significant effects over placebo and relaxation therapies. Levels of efficacy (migraine: efficacious, level 4; tension-type headache: efficacious and specific, level 5) and recommendations for future research are provided. Keywords: Migraine, tension-type headache, biofeedback, relaxation, treatment efficacy, meta-analysis, white paper Migraine and tension-type headache (TTH) are the two most prevalent and disabling headache condition in adults  ADDIN EN.CITE Rasmussen1991666617Rasmussen, B. K.Jensen, R.Schroll, M.Olesen, J.Epidemiology of headache in a general population: A prevalence studyJournal of Clinical EpidemiologyJournal of Clinical Epidemiology1147-115744111991(Rasmussen, Jensen, Schroll & Olesen, 1991) as well as in children and adolescents  ADDIN EN.CITE Kroener-Herwig2007656517Kroener-Herwig, B.Heinrich, M.Morris, L.Headache in german children and adolescents: a population-based epidemiological studyCephalalgiaCephalalgia519-5272762007(Kroener-Herwig, Heinrich & Morris, 2007). In North America migraine is experienced by 18% of women and 7% of men, with at least one attack per year  ADDIN EN.CITE Lipton200112212217Lipton, R.B.Stewart, W.F.Diamond, S.Diamond, M.L.Reed, M.Prevalence and burden of migraine in the United States: data from the American Migraine Study IIHeadacheHeadache646-657412001(Lipton, Stewart, Diamond, Diamond & Reed, 2001). The more common but less disabling episodic tension-type headache (ETTH) is estimated with a one-year prevalence of 38%, while the prevalence of chronic tension-type headache (CTTH), defined as having a frequency of at least 15 days per month, is estimated at 2%-3%  ADDIN EN.CITE Schwartz1998616117Schwartz, B. S.Steward, W. F.Simon, D.Lipton, R. B.Epidemiology of tension-type headacheJAMAJAMA381-38327951998(Schwartz, Steward, Simon & Lipton, 1998). Significant negative social and economic impacts resulting from these headache conditions have been reported  ADDIN EN.CITE Stovner2007646417Stovner, L. J.Hagen, K.Jensen, R.Katsarava, Z.Lipton, R. B.Scher, A. I.Steiner, T. J.Zwart, J.-A.The global burden of headache: a documentation of headache prevalence and disability worldwideCephalalgiaCephalalgia193-210272007(Stovner et al., 2007). Headache patients frequently experience deteriorated functional levels at home, work and school  ADDIN EN.CITE Molarius2006626217Molarius, A.Tegelberg, A.Recurrent haedache and migraine as a public health problem - A population-based study in swedenHeadacheHeadache73-81462006(Molarius & Tegelberg, 2006). Biofeedback treatments for pain emphasize the patients active role in managing these conditions, thereby establishing improved coping with the psychological and psychosocial consequences of pain. For the treatment of headache, several different feedback modalities are being used, focussing on multiple psychophysiological parameters more or less directly assumed to underlie the condition. To enhance efficacy, biofeedback is often combined with relaxation and cognitive-behavioral elements such as stress management. The measurement of treatment success, therefore, mostly includes psychophysiological and behavioral variables in addition to the symptom- related ones. Taking this diversity of treatment applications, components, and outcome measures into account is one of the challenges of efficacy reviews today. This comprehensive review will offer an independent evaluation of the efficacy of biofeedback for headache, including moderating effects of feedback modalities, outcome categories, and trial design. Efficacy recommendations, according to the guidelines jointly established by the Association for Applied Psychophysiology and Biofeedback (AAPB) and the International Society for Neurofeedback and Research (ISNR), will be put forward. In migraine, peripheral skin temperature feedback (TEMP-FB), blood-volume-pulse feedback (BVP-FB) and electromyographic feedback (EMG-FB) are the most prominent applications, while electroencephalographic feedback (EEG-FB) and galvanic skin response training (GSR-FB) are seldom used. The efficacy of biofeedback in treating migraine has been established in earlier reviews with improvement rates for pain from 40% to 65%  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980Blanchard19871241245Blanchard, E.B.Andrasik, FHatch, J.P.Fisher, J.G.Rugh, J.Biofeedback treatment of vascular headacheBiofeedback. Studies in clinical efficacy1-491987New YorkPlenum Press(Blanchard & Andrasik, 1987; Blanchard, Andrasik, Ahles, Teders & O'Keefe, 1980). Comparable treatment gains resulted for behavioral treatments and pharmacotherapies  ADDIN EN.CITE Holroyd199012512517Holroyd, K.A.Penzien, D.B.Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trialsPainPain1-13421990(Holroyd & Penzien, 1990). In a more recent review medium effect sizes for EMG-FB and TEMP-FB in combination with relaxation have been reported  ADDIN EN.CITE Goslin1271276Goslin, R.E.Gray, R.N.McCrory, D.C.Penzien, D.B.Rains, J.C.Hasselblad, V.Behavioral and physical treatments for migraine headache (Technical Review 2.2). Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. (NTIS Accession No. 127946). 1999.(Goslin et al. 1999). While this was the first review providing standardized measures of treatment effect, the number of integrated studies was very small (n=11) and confidence intervals for the resulting effects were rather broad. Also, analyses were limited to the two aforementioned feedback modalities, only post-treatment data were analysed, and no moderator analyses were performed. BVP-FB was excluded due to the technical difficulty in administering it. Further meta-analytic data integrations are needed to determine the short-term and long-term efficacy of BVP-FB and to establish treatment moderators for migraine. . The most frequently applied behavioral treatment option for TTH is EMG-FB, directed at reducing pericranial muscle activity. Previous quantitative reviews assessing the outcome of various behavioral treatments for TTH, including biofeedback, relaxation, cognitive therapy, and hypnotherapy  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980Holroyd1986787817Holroyd, J. C.Penzien, D.B.Client variables and the behavioural treatment of recurrent tension headache: a meta-analytic reviewJ Behav MedJ Behav Med515-53591986Bogaards1994737317Bogaards, M. C.ter Kuile, M. M.Treatment of recurrent tension headache: a meta-analytic reviewThe Clinical Journal of PainThe Clinical Journal of Pain174-190101994Haddock1997848417Haddock, C.K.Rowan, A.B.Andrasik, F.Wilson, P.G.Talcott, G.W.Stein, R.J.Home-based behavioural treatments for chronic benign headache: a meta-analysis of controlled trialsCephalalgiaCephalalgia113-118171997McCrory2001767617McCrory, D.Penzien, D.B.Hasselblad, V.Gray, R.Behavioural and physical treatments for tension-type and cervicogenic headachesDe Moines, IA: Foundation for Chiropractic Education and ResearchDe Moines, IA: Foundation for Chiropractic Education and Research2001(Blanchard et al., 1980; Bogaards & ter Kuile, 1994; Haddock et al., 1997; Holroyd & Penzien, 1986; McCrory, Penzien, Hasselblad & Gray, 2001) have shown average improvement rates for pain from 46%  ADDIN EN.CITE Holroyd1986787817Holroyd, J. C.Penzien, D.B.Client variables and the behavioural treatment of recurrent tension headache: a meta-analytic reviewJ Behav MedJ Behav Med515-53591986(Holroyd & Penzien, 1986) to 61%  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980(Blanchard et al., 1980), exceeding those of no-treatment conditions  ADDIN EN.CITE Bogaards1994737317Bogaards, M. C.ter Kuile, M. M.Treatment of recurrent tension headache: a meta-analytic reviewThe Clinical Journal of PainThe Clinical Journal of Pain174-190101994(Bogaards & ter Kuile, 1994). Two meta-analyses investigating psychological headache treatments have provided standardized measures of treatment success for pain. McCrory and colleagues  ADDIN EN.CITE McCrory2001767617McCrory, D.Penzien, D.B.Hasselblad, V.Gray, R.Behavioural and physical treatments for tension-type and cervicogenic headachesDe Moines, IA: Foundation for Chiropractic Education and ResearchDe Moines, IA: Foundation for Chiropractic Education and Research2001(2001) have reported medium-to-large average effects for EMG-FB in adults, while Trautmann and colleagues  ADDIN EN.CITE Trautmann2006727217Trautmann, E.Lackschewitz, H.Krner-Herwig, B.Psychological treatment of recurrent headache in children and adolescents - a meta-analysisCephalalgiaCephalalgia1411-1426262006(Trautmann, Lackschewitz & Krner-Herwig, 2006) documented small-to-medium effect sizes for the efficacy of psychological headache treatments in children and adolescents. Specific comparisons of biofeedback for TTH to other behavioral headache treatments have not yet been meta-analytically integrated. Likewise the long-term effects of biofeedback for TTH, the efficacy on different outcome measures, and treatment moderators have not yet been systematically analysed. Notably, none of the previous reviews for migraine or TTH have integrated effect sizes for outcome variables other than headache or medication. In the light of these limitations two recent meta-analyses have established scientifically sound evidence supporting the utility of biofeedback for migraine and TTH  ADDIN EN.CITE Nestoriuc2007707017Nestoriuc, Y.Martin, A.Efficacy of biofeedback for migraine: A meta-analysisPainPain111-1271282007Nestoriucin press12112117Nestoriuc, Y.Rief, W.Martin, A.Meta-analysis of biofeedback for tension-type headache: Efficacy, specificity, and treatment moderatorsJournal of Consulting and Clinical PsychologyJournal of Consulting and Clinical Psychologyin press(Nestoriuc & Martin, 2007; Nestoriuc, Rief & Martin, 2008). The objective of this comprehensive review is to present an up-to-date evaluation of the efficacy of biofeedback for headache. Drawing upon the two most recent meta-analyses in the field, evidence was incorporated, assessed, and documented according to the guidelines for the evaluation of the clinical efficacy of psychophysiological interventions  ADDIN EN.CITE LaVaque200212612617LaVaque, T. J.Hammond, D. C.Trudeau, D.Monastra, V.Perry, J.Lehrer, P.Matheson, D.Sherman, R.Template for developing guidelines fir the evaluation of the clinical efficacy of psychophysiological interventions. Efficacy task forceApplied Psychophysiology and BiofeedbackApplied Psychophysiology and Biofeedback273-281272002(LaVaque et al., 2002). Analysed were the short- and long-term efficacy of biofeedback for migraine and TTH, treatment specificity, differential treatment effects in the form of pain measures, psychological, behavioral, and physiological outcome categories, as well as predictors of treatment success, such as patient characteristics and therapy features. Specific meta-analytic techniques were applied to control for possible confounding effects of selective publication, dropout, and study validity. Methods Definitions and operationalizations Condition of interest: This biofeedback efficacy review covers two conditions of interest (COI), i.e., migraine and TTH. Diagnoses were based on a standardized classification system (i.e., IHS, 2004; IHS, ADDIN EN.CITE 198811911917Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.CephalalgiaCephalalgia1-9681988 1988; Ad Hoc Classification System, ADDIN EN.CITE 1962828217Ad Hoc Committee on the classification of headache: Classification of headacheJAMAJAMA117-1181791962 1962) or an exact description of the disorder including characteristic features of migraine (i.e., severe pain, throbbing character, nausea, phono/photophobia or aura) or TTH (i.e., mild to moderate pain intensity, bilateral, nonpulsating quality, pressing or tightening, band like feeling, no exacerbation by exercise). Double diagnoses of TTH and migraine (mixed or combination headache) were excluded. Types of interventions: This review focussed on individually administered biofeedback treatments (TEMP-FB, EMG-FB, BVP-FB, EEG-FB, GSR-FB, or biofeedback in combination with other behavioral therapies). Outcome variables: Frequency of pain measured with a structured headache diary was considered the primary outcome variable for this review, as recommended by the International Headache Society (IHS ADDIN EN.CITE 2000939317International headache society clinical trials subcommittee. Guidelines for controlled trials of drugs in migraine: second edition.CephalalgiaCephalalgia765-786202000, 2000), the AHS Behavioral Clinical Trials Workgroup (Penzien et al., 2005), and Andrasik, Lipchik, McCrory, and Wittrock (2005). Included as secondary outcome variables were intensity and duration of pain as well as headache and medication indices measured with headache diaries or pain scales, anxiety, depression, self-efficacy, and physiological parameters. Study inclusion criteria: In addition to fulfilling the criteria mentioned before (COI, treatment, outcome) studies included in this review had to be published in English or German and report sufficient statistical data to allow the calculation of effect sizes. Excluded were studies with less than 4 patients per treatment arm and case studies. Search procedure For the purpose of this review, the literature searches conducted in the two meta-analyses by Nestoriuc and Martin (2007) and Nestoriuc et al. (2008) were updated. We used three international and one German databases (Medline, PsycInfo, CENTRAL, and Psyndex from the first available year to March 2008) using the search terms biofeedback or behavioral treatment or cognitive therapy or nonpharmacological or applied psychophysiology. For the COI migraine these terms were paired with migraine, vascular headache or mixed headache and for TTH with tension-type headache, muscle contraction headache, tension headache or chronic headache. In addition to the formerly reviewed studies this search revealed 14 new studies, of which only two were treatment outcome studies. Five studies were reviews or meta-analyses, another five described treatment and assessment of headache conditions without evaluating them directly, and two were experimental investigations. Of the two outcome studies, one was included in the current review  ADDIN EN.CITE Martin200712912917Martin, Paul R.Forsyth, Michael R.Reece, JohnCognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headacheBehavior Therapy. VolBehavior Therapy. Vol350-363384headache (migraine, tension-type)2007(Martin, Forsyth & Reece, 2007), the other one was excluded because no headache outcome variables were reported  ADDIN EN.CITE Ciancarelli200713013017Ciancarelli, I.Tozzi Ciancarelli, M. G.Spacca, G.Di Massimo, C.Carolei, A.Relationship between biofeedback and oxidative stress in patients with chronic migraineCephalalgiaCephalalgia1136-412710headache (migraine)healthy subjects2007(Ciancarelli, Tozzi Ciancarelli, Spacca, Di Massimo & Carolei, 2007). Finally, a total of 94 studies met our criteria and were included this review (see Appendix A for a complete reference list of the studies integrated in this white paper). Study coding and validity assessment For each study, clinical and methodological aspects were coded with a structured coding scheme, including a 12-item validity scale (see Appendix B for the Study Coding and Validity Assessment Scale). After training in the use of the coding system, all studies were coded by the first author and two independent reviewers (graduate students). A random sample of 20% of the migraine and all of the TTH studies were coded twice to establish reliability of the coding process. The reliability of the coding form as well as the interrater-agreement for the validity scale were proven satisfactory with mean reliability indices ranging from .84 to .91. The evaluation of the randomization procedure (e.g., randomized or quasi-randomized according to pre-existing criteria) or the therapy manual (e.g., provided manual or brief description of procedures) led to more disagreement than the coding of quantitative study aspects. Coding discrepancies were discussed and resolved. Meta-analytic procedures Effect size calculation and integration: Standardized effect sizes using Hedges g  ADDIN EN.CITE Hedges19851011016Hedges, L.V.Olkin, I.Statistical methods for meta-analysis1985OrlandoAcademic Press(Hedges & Olkin, 1985) for controlled trials and its pre-post equivalent for uncontrolled studies  ADDIN EN.CITE Gibbons199310410417Gibbons, R.D.Hedecker, D.R.Davis, J.M.Estimation of effect size from a series of experiments involving paired comparisonsJournal of Educational StatisticsJournal of Educational Statistics18271-91993(Gibbons, Hedecker & Davis, 1993) were calculated for each outcome variable, treatment group and time point. The correction for small samples was applied  ADDIN EN.CITE Hedges19851011016Hedges, L.V.Olkin, I.Statistical methods for meta-analysis1985OrlandoAcademic Press(Hedges & Olkin, 1985). Multiple effect sizes from a single study were averaged with covariance adjustment prior to effect integration. Independent effect sizes were weighted by their individual sample size. Separate integrations were carried out with respect to different treatment comparisons, feedback modalities, outcome categories, and time points. Contingent with the homogeneity statistic Q  ADDIN EN.CITE Shadish19941121125Shadish, W. R.Haddock, C.K.Cooper, H.Hedges, L.V.Combining estimates of effect sizeThe handbook of research synthesis261-811994New YorkRussel Sage(Shadish & Haddock, 1994) fixed effect models or random effect models (REM) were applied to compute average effect sizes and confidence intervals. Moderating effects of patient, treatment, and study characteristics were tested with planned contrasts and weighted multiple regression analysis. Sensitivity analyses: Meta-analytic results can be biased due to the fact that studies with nonsignificant results are less likely to be published than those with significant results. This potential bias is called publication bias and can lead to an overestimation of treatment effects. To control for this bias, we calculated the number of studies with effect sizes of zero (i.e., fail-safe n rates) that would be needed to reduced the established average effect to insignificance  ADDIN EN.CITE Rosenthal197911311317Rosenthal, R.The "file drawer problem" and tolerance for null resultsPsychological BulletinPsychological Bulletin638-41861979(Rosenthal, 1979). Intention-to-treat-analyses with a modified last-observation-carried-forward approach were applied to control for potential biases due to treatment dropout. Patients who dropped out of a study after treatment assignment were considered nonresponders and henceforth represented with zero effect sizes (i.e., no change in outcome variables). The individual completer effect sizes were corrected with those intention-to-treat effects within each study and then reintegrated. Results Characteristics of included studies Included in this review were 94 studies, representing data from over 3,500 headache patients, that have been published between 1973 and 2007. Included in the meta-analysis of biofeedback for migraine were 56 studies with a mean of 40 patients per study. The meta-analysis on TTH consisted of 45 studies with a mean of 29 patients per study. In 7 of these studies treatment was provided for both migraine and TTH patients, and results were scored and presented independently. Key features of the integrated studies are presented in Table 1. Age means and gender distributions were similar for the two COI, with 37 and 38 years on average, and 88% and 73% percent women for Migraine and TTH, respectively. The TTH sample additionally included 9 studies investigating the efficacy of biofeedback for children and adolescents. In the studies with adult headache patients, the average number of years since headache diagnosis was 17.1 for migraine and 14.8 for TTH. Diagnoses were made according to a standardized diagnostic system in 80% of the migraine studies and in 50% of the TTH studies. Unstandardized exams and interviews applying characteristic features of the two COI were used for diagnostic purposes in 7% of the migraine and in 34% of the TTH studies. In the remaining 13% of the migraine and 16% of the TTH studies patients prior medical diagnoses were adopted from their records or interviews. During biofeedback treatment, 14% of the migraine and 8% of the TTH patients discontinued treatment. Information about attrition was provided in 76% of the migraine and 61% of the TTH studies. During follow-up, an additional 6% of migraine patients and 25% of the TTH patients ceased participation. Follow-up evaluations took place 14 months after treatment termination on average. In total, 136 active biofeedback conditions were investigated. For migraine, TEMP-FB in combination with either relaxation or EMG-FB, was the most frequently applied feedback modality, followed by TEMP-FB alone and BVP-FB. Seldom used were EMG-FB alone, EEG-FB and GSR-FB. For TTH, 92% of the biofeedback treatments were EMG-FB. Of these 16% were applied in combination with relaxation training. Other modalities were seldom used. In 80% of the EMG-FB treatments electrodes were placed bifrontal, in 12% multiple placements (i.e., frontal, neck or jaw) were used, and in 8% electrodes were placed on the neck. The number of biofeedback sessions ranged from 3 to 24 with an average of 11 sessions for both migraine and TTH. The duration of a treatment session ranged from 20 to 95 minutes, averaging 43 minutes for the two COI. In 78% of the migraine studies and 80% of the TTH studies treatment manuals were utilized and described in the publications. 78% of the integrated migraine studies and 58% of the TTH studies were conducted with control groups. The remaining 22% of the migraine studies and 42% of the TTH studies were uncontrolled pre-post evaluations. Within the controlled trials waiting list/ no-treatment control groups were applied in 15 of the migraine and 8 of the TTH studies. Placebo control groups were applied in 12 of the migraine and 8 of the TTH studies. The placebo treatments were mostly pseudofeedback conditions, where patients were trained to influence psychophysiological parameter under false or stable feedback or in the opposite direction (e.g., increase of muscle tension). Active control treatments included relaxation training in 18% of the migraine and 11% of the TTH studies. Within the controlled studies, 26% of the migraine and 22% of the TTH studies incorporated single or double-blind designs. Outcome was measured with headache parameters, and at least one other outcome category, in 84% of the migraine and 68% of the TTH studies. Means and standard deviations of the outcome variables that can be directly used for the calculation of effect sizes were presented in 73% of the migraine and 46% of the TTH studies. Efficacy of biofeedback in controlled trials For the analysis of general efficacy, the variables headache frequency, duration, and intensity were integrated. These outcome variables were consistently measured with a structured headache diary in 92% of the migraine and 83% of the TTH studies. Mean weighted effect sizes for all controlled comparisons are presented in Table 2. In the migraine studies, biofeedback yielded a significant small-to-medium effect size in comparison to waiting list control groups. An average small-to-medium effect size was found in comparison to placebo groups. However, this effect missed formal significance. A small non-significant effect in comparison to relaxation treatments was established. In the TTH studies, biofeedback yielded a significant medium-to-large effect size as compared to untreated control groups. A significant medium effect size was found in comparison to placebo control groups and a significant small effect size for biofeedback was obtained in comparison to relaxation control groups. For all reported comparisons, effect sizes were homogeneous according to the REM. The comparisons of biofeedback with pharmacotherapy, and physical and cognitive therapies, were insignificant and consisted of too few studies to provide reliable conclusions. Efficacy in pre-post and follow-up evaluations Additional pre-post effect sizes were computed for all controlled and uncontrolled comparisons. Weighted mean effect sizes and confidence intervals for all pre-post and follow-up integrations are presented in Table 3. For migraine, 85 independent effect sizes ranging from -0.07 to 1.74 were computed. These effects were homogeneous in the fixed effect model. For all biofeedback modalities, a significant average effect size of medium magnitude resulted. This effect was proven to be robust in intention-to-treat analysis. Over 14 months follow-up, on average, a significant medium-to-large average effect size resulted. Reliability of the follow-up effects was established in the intention-to-treat analysis as well. For TTH, the effect size calculation yielded 49 independent effect measures for headache relief from pre to post-treatment, ranging from 0.06 to 1.99. Effect size integration in the random effects model resulted in a significant large average effect size. In the intention-to-treat analysis, this effect size was shown to be reliable. Over an average 14 month follow-up, this effect was maintained and somewhat enhanced with an average medium-to-large effect size. Evaluation of the follow-up effect sizes in intention-to-treat analysis resulted in a significant medium-to-large average effect size. Efficacy of different feedback modalities for migraine Effect sizes with confidence intervals for the feedback modalities utilized in the biofeedback treatment of migraine are shown in Figure 1. All feedback modalities showed significant effect sizes. The highest treatment gains resulted for BVP-FB, with an average medium-to-large effect size. An overall medium effect size resulted for TEMP-FB in combination with relaxation and EMG-FB, while small-to-medium effect sizes resulted for EMG-FB and TEMP-FB alone. Differences between the modalities were insignificant. Effects of biofeedback on different types of outcome variables Weighted average effect sizes and confidence intervals for all outcome variables are depicted in Figure 2a for the migraine studies and in Figure 2b for the TTH studies. In migraine, frequency, intensity, duration, and the headache-index were all reduced with significant medium effect sizes. Differences between these outcome categories were insignificant. For medication consumption, a small-to-medium effect size resulted. This effect was significantly smaller than the reduction on headache frequency and duration. Significant stronger improvements were shown for self-efficacy. Here a significant medium-to-large effect size resulted. Depression and anxiety showed medium effects, with confidence intervals ranging from small to large. In the TTH studies, headache frequency, intensity, and the headache-index were reduced with large average effect sizes. Duration of headache episodes was reduced with a small-to-medium effect size. Physiological outcome (i.e., muscle tension in microvolts) was assessed as changes in muscle tension from baseline to post-treatment, and in some studies, additional within-session changes were reported. Muscle tension was reduced with a significant medium-to-large effect size within treatment sessions and with a significant small effect size (confidence interval including medium effects) across sessions. Over the course of all biofeedback sessions, reductions in headache-index and frequency were significantly larger than the reductions in muscle tension. Self-efficacy, anxiety, and depression all yielded significant medium effect sizes, with corresponding confidence intervals ranging from small to large effect sizes. Medication intake was reduced with a significant small-to-medium effect size. The average effect size for headache-index was significantly higher than the effect size for medication intake. The other symptom categories did not show any significant differences. Publication bias In addition to the graphical method (see funnel plots in Nestoriuc & Martin, 2007), we examined publication bias by calculating fail-safe ks for the critical effect sizes 0.01 and 0.20. For migraine and TTH over 4,000 unpublished studies with zero effects would be necessary to reduce the observed average effect to zero. For a reduction to an average effect size of small magnitude (0.20) 148 migraine and 168 TTH studies with zero effects would be required. In sum, publication bias seems rather unlikely. Discussion This white paper review provides an up-to date evaluation of the efficacy of biofeedback as a behavioral treatment option for headache. The integration of 102 studies with over 140 active biofeedback treatment conditions allows us to draw generalizable conclusions regarding the efficacy of biofeedback. Depicted are data from over 3,500 headache patients with an average chronicity of migraine and TTH of over 14 years. The results apply for adult and geriatric headache patients. General efficacy and specificity Overall robust treatment effects of medium magnitude were established for migraine and TTH respectively. Effects are clinically meaningful as they demonstrate symptom improvements of over half a standard deviation for migraine and almost one standard deviation for patients suffering from TTH. The high chronicity of the sample with over 14 years of headache on average further supports the clinical significance of these results. With an overall average of 11 sessions biofeedback treatments were altogether short and economical. Furthermore, the treatment was generally very well accepted, as shown in the low dropout rates. For migraine, a medium average effect size resulted for biofeedback in comparison to untreated control groups. This effect size corresponds with symptom improvements in headache scores exceeding those of 61% of the patients in the untreated control groups  ADDIN EN.CITE Rosenthal198213113117Rosenthal, R.Rubin, D.B.A Simple, General Purpose Display of Magnitude of Experimental Effect.Journal of Educational PsychologyJournal of Educational Psychology166-169741982(Rosenthal & Rubin, 1982). As indicated by the confidence interval, migraine patients treated with biofeedback will likely experience symptom improvements of 56-65% over and above those of an average patient in a waiting list control group. Although a small effect size for biofeedback in comparison to placebo was found, biofeedback treatment gains were not reliably higher than improvements in placebo feedback groups (i.e., psychological placebo for biofeedback including TEMP-FB with finger cooling). The average effect size found in comparison to placebo groups corresponds to a 56% success rate in biofeedback compared to 44% (38-50%) improvement in the placebo groups. Likewise differences between biofeedback and relaxation showed no significance in migraine. Thus, there is strong evidence for the efficacy, but only weak evidence for the treatment specificity of biofeedback in migraine. In TTH a large average effect size resulted for EMG-FB in comparison to untreated control groups. This effect corresponds with a 69% success rate under biofeedback as opposed to a 31% (25-37%) chance of improvement in the untreated control groups. Superior clinical results also emerged for biofeedback compared to placebo control groups and relaxation therapies. The effect size over placebo was robust and of medium magnitude, corresponding with a 62% success rate versus 38% (34-43%) in the placebo groups. Similar improvement rates for medication placebo were documented by Blanchard, Andrasik et al. (1980). However, the improvements in placebo groups seemed to be higher in migraine than in TTH patients. The effect size over relaxation was small but reliable, corresponding with a 55% success rate versus 45% (42-48%) in the relaxation groups. Strong evidence regarding the efficacy as well as the specificity of biofeedback for TTH can be drawn from these results. Further efficacy comparisons of biofeedback to pharmacotherapy, physical therapy and cognitive therapy included only very few studies and cannot be interpreted reliably at this point. Results of previous reviews have consistently shown biofeedback to be more effective than headache monitoring  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980Holroyd1986787817Holroyd, J. C.Penzien, D.B.Client variables and the behavioural treatment of recurrent tension headache: a meta-analytic reviewJ Behav MedJ Behav Med515-53591986Bogaards1994737317Bogaards, M. C.ter Kuile, M. M.Treatment of recurrent tension headache: a meta-analytic reviewThe Clinical Journal of PainThe Clinical Journal of Pain174-190101994McCrory2001767617McCrory, D.Penzien, D.B.Hasselblad, V.Gray, R.Behavioural and physical treatments for tension-type and cervicogenic headachesDe Moines, IA: Foundation for Chiropractic Education and ResearchDe Moines, IA: Foundation for Chiropractic Education and Research2001(Blanchard et al., 1980; Bogaards & ter Kuile, 1994; Holroyd & Penzien, 1986; McCrory et al., 2001), but were inconclusive about the specificity of biofeedback. Blanchard, Andrasik, and colleagues  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980(1980) pointed out nearly 30 years ago that there were too few studies to draw conclusions about the equivalence of alternative headache treatments. Holroyd and Penzien  ADDIN EN.CITE Holroyd1986787817Holroyd, J. C.Penzien, D.B.Client variables and the behavioural treatment of recurrent tension headache: a meta-analytic reviewJ Behav MedJ Behav Med515-53591986(1986) reported significant differences between behavioral treatments and placebo conditions, but no differences within the active treatments. Until today, many studies have reported conflicting results with respect to the comparative efficacy of biofeedback and relaxation training, mostly due to underpowered statistical analyses  ADDIN EN.CITE Houle2005979717Houle, T.T.Penzien, D.B.Houle, C.K.Statsitical power and sample size estimation for headaceh research: an overview and power calculation toolsHeadacheHeadache414-8452005(Houle, Penzien & Houle, 2005). The results of this review point to a comparable efficacy of biofeedback and relaxation therapy in the case of migraine and to a superiority of biofeedback over relaxation in the treatment of TTH. The efficacy findings from controlled comparisons were subsequently replicated in pre-post treatment comparisons. All available outcome data from the integrated randomized controlled as well as uncontrolled studies were included in the pre-post treatment comparisons. Robust medium average effect sizes resulted for the two COI, with a confidence interval including large effects for TTH. This review is the first to include intention-to-treat analyses for efficacy evaluations in behavioral headache treatments. The inclusion of all patients who dropped out of the active biofeedback groups during treatment resulted in slightly diminished but still significant medium average effect sizes for migraine and TTH. These results point to the robustness and clinical meaningfulness of the established effects, even when dropouts are considered as nonresponders. Maintenance of biofeedback effects over time In follow-up evaluations, the established effects were shown to persist up to several years after treatment. One study showed this to be the case whether additional treatment, in the form of booster sessions, was provided or not (Andrasik, Blanchard, Neff, & Rodichok, 1984). The average medium effect sizes remained stable over follow-up intervals of 15 months for migraine and TTH. Supporting prior results  ADDIN EN.CITE Blanchard1980757517Blanchard, E. B.Andrasik, F.Ahles, T. A.Teders, S.J.O'Keefe, D.Migraine and tension headache: A meta-analytic reviewBehavior TherapyBehavior Therapy613-631115headache (migraine)headache (tension-type)1980(Blanchard et al., 1980) indicating the stability of biofeedback treatment gains, the presented results constitute the most comprehensive meta-analytical confirmation of the long-term efficacy of biofeedback for headache disorders. Intention-to-treat analysis showed that the established follow-up effects persisted even when dropouts were considered as nonresponders. Moderating effects of different feedback modalities and outcome measures The frequently applied feedback modalities in migraine all showed comparable treatment effects with reasonable confidence. The rarely investigated applications resulted in medium effects as well but produced less stable results. Among these, EEG-FB was applied in three studies only, showing small and medium effect sizes. Due to the small number of integrated studies, it is not possible to draw final conclusions regarding the efficacy of EEG-FB for migraine. It is both interesting and important to note that BVP-FB, a modality that has been excluded from prior efficacy reviews  ADDIN EN.CITE Goslin1271276Goslin, R.E.Gray, R.N.McCrory, D.C.Penzien, D.B.Rains, J.C.Hasselblad, V.Behavioral and physical treatments for migraine headache (Technical Review 2.2). Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. (NTIS Accession No. 127946). 1999.(Goslin et al. 1999), showed the highest improvement rates; effect sizes ranged into large effects. In TTH a differential analysis of feedback modalities is not necessary, as the majority of studies used EMG-Feedback. With respect to the different outcome variables that have been evaluated, reliable effect sizes occurred for all headache variables. Headache frequency, the primary outcome variable, yielded the highest treatment effects in migraine and TTH. Also, consistently over both COI, the reduction in medication consumption, though robustly present, yielded the lowest effect sizes. In migraine, cognitive aspects, as measured with changes in self-efficacy, yielded higher effect sizes than the other outcomes. In TTH, the reductions in muscle tension as a measure of physiological outcome yielded similarly high effect sizes to the cognitive variables. Anxiety and depression were less often evaluated, resulting in rather imprecise estimated effects. It has to be noted that these results cannot be used to analyze treatment mediators, because the incorporated effect measures are only based on pre-and post-treatment assessment. It is highly recommended to incorporate mediator analyses in future headache trials  ADDIN EN.CITE Penzien2005989817Penzien, D.B.Rains, J.C.Lipchik, G.L.Nicholson, R.A.Lake, A.E.Hursey, K.G.Future directions in behavioural headache research: applications for an evolving healthcare environmentHeadacheHeadache526-34452005(Penzien et al., 2005) in order to gain further insight into treatment mechanisms. Promising variables in that respect are self-efficacy and physiological changes, as well as comorbid reductions in depression and anxiety. There are some additional behavioral and socioecomic outcome categories that have seldom been assessed in the current headache trials (i.e., lost work days, health service use, general activity level, social and role functioning). Thus, in future studies we recommend incorporating direct measures of the functional, social, and socioeconomic burden of headache (Andrasik, 2001; Andrasik et al., 2005). Influence of treatment features, patient characteristics, and study validity Analyses of treatment moderators are used to derive recommendations for the clinical utility of treatments. Our moderator analyses in the two recently published meta-analyses on migraine and TTH have established important treatment moderators, which we will briefly describe in the following section. In the biofeedback treatment of migraine, home training was shown to be an essential component of the efficacy and maintenance of treatment benefits. Treatment manuals incorporating home training led to nearly 20% higher treatment effects for headache reduction. Surprisingly, headache chronicity turned out to be a positive treatment predictor both in adult migraine and TTH patients. This effect accounted for over 20% of the variability in the TTH effect sizes and turned out to be a significant predictor for direct treatment efficacy and follow-up effects in migraine. It might be partly due to particularly high effects in geriatric headache patients  ADDIN EN.CITE Nicholson1993414117Nicholson, Nancy L.Blanchard, Edward B.State U New York, Albany, USA controlled evaluation of behavioral treatment of chronic headache in the elderlyBehavior TherapyBehavior Therapy395-408243combined relaxation training and cognitive therapy and biofeedback, 61 80yr olds with chronic tension and/or migraine headache, 1 mo followupBehavioral and Psychological Treatment of Physical Illness336133Adulthood (18 yrs and older)Aged (65 yrs and older)Human199319931994-26860-001http://www.aabt.org111(Nicholson & Blanchard, 1993). However, the fact that more years with headache can lead to higher treatment benefits emphasizes the treatment possibilities inherent in biofeedback. In the treatment of TTH, the combination of biofeedback with relaxation training, and the use of biofeedback alone can be recommended, especially for juvenile headache patients. No moderating effects were found for different training sites within the EMG-FB treatments, for study setting (i.e., outpatient versus including home training), treatment duration, or the diagnostic distinctions between CTTH, ETTH, and TTH with pericranial tenderness. Diagnostic distinctions between ETTH and the clinically more meaningful CTTH were only seldom made. Hence it is not yet possible to draw reliable conclusions regarding the equal effectiveness of EMG-FB for both headache conditions. Further studies directly comparing the efficacy of EMG-FB for episodic and chronic TTH are needed. The validity levels of the integrated studies were uncorrelated with the treatment effects for both COI at post-treatment. Nevertheless, some validity issues seem present in the field of biofeedback  ADDIN EN.CITE Yucha200213213217Yucha, C.B.Problems inherent in assessing biofeedback efficacy studiesApplied Psychophysiology and BiofeedbackApplied Psychophysiology and Biofeedback99-106272002(Yucha, 2002). In some of the studies evaluated in this review, low sample sizes, resulting in power problems, failure to describe basic treatment and patient characteristics, as well as the use of unstructured diagnostic systems had a negative impact on validity levels. A number of excellent suggestions and recommendations concerning behavioral headache research have recently been put forward  ADDIN EN.CITE Rains200511811817Rains, J.C.Penzien, D.B.McCrory, D.C.Gray, R.N.Behavioral headache treatment: history, review of empirical literature, and methodological critiqueHeadacheHeadache92-109452005Houle2005979717Houle, T.T.Penzien, D.B.Houle, C.K.Statsitical power and sample size estimation for headaceh research: an overview and power calculation toolsHeadacheHeadache414-8452005Penzien2005989817Penzien, D.B.Rains, J.C.Lipchik, G.L.Nicholson, R.A.Lake, A.E.Hursey, K.G.Future directions in behavioural headache research: applications for an evolving healthcare environmentHeadacheHeadache526-34452005(Houle, Penzien & Houle, 2005; Penzien et al., 2005; Rains, Penzien, McCrory & Gray, 2005), and future studies would undoubtedly benefit from adopting these standards. Levels of evidence of efficacy The evidence collected and presented in this comprehensive efficacy review leads to the conclusion that biofeedback for migraine can be supported as an efficacious treatment option. This constitutes Level 4 evidence according to the AAPB/ ISNR criteria  ADDIN EN.CITE LaVaque200212612617LaVaque, T. J.Hammond, D. C.Trudeau, D.Monastra, V.Perry, J.Lehrer, P.Matheson, D.Sherman, R.Template for developing guidelines fir the evaluation of the clinical efficacy of psychophysiological interventions. Efficacy task forceApplied Psychophysiology and BiofeedbackApplied Psychophysiology and Biofeedback273-281272002(LaVaque et al., 2002). Efficacy comparisons to no-treatment control groups favoring biofeedback exist in studies from multiple independent research teams, using clearly defined diagnostic criteria and outcome measures as well as appropriate data analysis. Biofeedback for TTH can be supported as an efficacious and specific treatment option. According to the AAPB/ ISNR criteria this constitutes the highest level of evidence (Level 5), reserved for psychophysiological interventions, that have established Level 4 evidence and have shown additional superior treatment results in comparisons to credible sham therapy or alternative bona fide treatments. References  ADDIN EN.REFLIST Ad Hoc Committee on the classification of headache: Classification of headache. (1962). JAMA, 179, 117-118. Andrasik, F. (2001). Migraine and quality of life: Psychological considerations. Journal of Headache and Pain, 2, 1-9. Andrasik, F., Blanchard, E.B., Neff, D.F., & Rodichok, L.D. (1984). Biofeedback and relaxation training for chronic headache: A controlled comparison of booster treatments and regular contacts for long-term maintenance. Journal of Consulting and Clinical Psychology, 52, 609-615. Andrasik, F., Lipchik, G.L., McCrory, D.C., & Wittrock, D.A. (2005). Outcome measurement in behavioral headache research: Headache parameters and psychosocial outcomes. Headache, 45, 429-437. Blanchard, E. B., & Andrasik, F. (1987). Biofeedback treatment of vascular headache. In J. P. Hatch, J. G. Fisher & J. Rugh (Eds.), Biofeedback. Studies in clinical efficacy (pp. 1-49). New York: Plenum Press. Blanchard, E. B., Andrasik, F., Ahles, T. A., Teders, S. J., & O'Keefe, D. (1980). Migraine and tension headache: A meta-analytic review. Behavior Therapy, 11(5), 613-631. Bogaards, M. C., & ter Kuile, M. M. (1994). Treatment of recurrent tension headache: a meta-analytic review. The Clinical Journal of Pain, 10, 174-190. Ciancarelli, I., Tozzi Ciancarelli, M. G., Spacca, G., Di Massimo, C., & Carolei, A. (2007). Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia, 27(10), 1136-1141. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2 ed.). Hillsdale: Erlbaum. Gibbons, R. D., Hedecker, D. R., & Davis, J. M. (1993). Estimation of effect size from a series of experiments involving paired comparisons. Journal of Educational Statistics, 18(271-9). Goslin, R. E., Gray, R. N., McCrory, D. C., Penzien, D. B., Rains, J. C., & Hasselblad, V. Behavioral and physical treatments for migraine headache (Technical Review 2.2). Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. (NTIS Accession No. 127946). 1999. Haddock, C. K., Rowan, A. B., Andrasik, F., Wilson, P. G., Talcott, G. W., & Stein, R. J. (1997). Home-based behavioral treatments for chronic benign headache: a meta-analysis of controlled trials. Cephalalgia, 17, 113-118. Headache Classification Committee of the International Headache Society. The International Classification of headache disorders, 2nd edition. (2004). Cephalalgia, 24(Suppl. 1), 1-151. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. (1988). Cephalalgia, 8, 1-96. Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. Orlando: Academic Press. Holroyd, K. A., & Penzien, D. B. (1986). Client variables and the behavioral treatment of recurrent tension headache: a meta-analytic review. J Behav Med, 9, 515-535. Holroyd, K. A., & Penzien, D. B. (1990). Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain, 42, 1-13. Houle, T. T., Penzien, D. B., & Houle, C. K. (2005). Statsitical power and sample size estimation for headaceh research: an overview and power calculation tools. Headache, 45, 414-418. International headache society clinical trials subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. (2000). Cephalalgia, 20, 765-786. Kroener-Herwig, B., Heinrich, M., & Morris, L. (2007). Headache in german children and adolescents: a population-based epidemiological study. Cephalalgia, 27(6), 519-527. LaVaque, T. J., Hammond, D. C., Trudeau, D., Monastra, V., Perry, J., Lehrer, P., et al. (2002). Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological interventions. Efficacy task force. Applied Psychophysiology and Biofeedback, 27, 273-281. Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001). Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache, 41, 646-657. Martin, P. R., Forsyth, M. R., & Reece, J. (2007). Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behavior Therapy. Vol, 38(4), 350-363. McCrory, D., Penzien, D. B., Hasselblad, V., & Gray, R. (2001). Behavioral and physical treatments for tension-type and cervicogenic headaches. De Moines, IA: Foundation for Chiropractic Education and Research. Molarius, A., & Tegelberg, A. (2006). Recurrent haedache and migraine as a public health problem - A population-based study in Sweden. Headache, 46, 73-81. Nestoriuc, Y., & Martin, A. (2007). Efficacy of biofeedback for migraine: A meta-analysis. Pain, 128, 111-127. Nestoriuc, Y., Rief, W., & Martin, A. (2008). Meta-analysis of biofeedback for tension-type headache: Efficacy, specificity, and treatment moderators. Journal of Consulting and Clinical Psychology. 76 (3), 379-396. Nicholson, N. L., & Blanchard, E. B. (1993). A controlled evaluation of behavioral treatment of chronic headache in the elderly. Behavior Therapy, 24(3), 395-408. Penzien, D.B., Andrasik, F., Freidenberg, B.M., Houle, T.T., Lake, A.E., III, Lipchik, G.L., Holroyd, K.A., Lipton, R.B., McCrory, D.C., Nash, J.M., Nicholson, R.A., Powers, S.W., Rains, J.C., & Wittrock, D.A. (2005). Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache, 45 (Suppl 2), S110-S132. Penzien, D. B., Rains, J. C., Lipchik, G. L., Nicholson, R. A., Lake, A. E., & Hursey, K. G. (2005). Future directions in behavioral headache research: applications for an evolving healthcare environment. Headache, 45, 526-534. Rains, J. C., Penzien, D. B., McCrory, D. C., & Gray, R. N. (2005). Behavioral headache treatment: history, review of empirical literature, and methodological critique. Headache, 45, 92-109. Rasmussen, B. K., Jensen, R., Schroll, M., & Olesen, J. (1991). Epidemiology of headache in a general population: A prevalence study. Journal of Clinical Epidemiology, 44(11), 1147-1157. Rosenthal, R. (1979). The "file drawer problem" and tolerance for null results. Psychological Bulletin, 86, 638-641. Rosenthal, R., & Rubin, D. B. (1982). A Simple, General Purpose Display of Magnitude of Experimental Effect. Journal of Educational Psychology, 74, 166-169. Schwartz, B. S., Steward, W. F., Simon, D., & Lipton, R. B. (1998). Epidemiology of tension-type headache. JAMA, 279(5), 381-383. Shadish, W. R., & Haddock, C. K. (1994). Combining estimates of effect size. In H. Cooper & L. V. Hedges (Eds.), The handbook of research synthesis (pp. 261-281). New York: Russel Sage. Stovner, L. J., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R. B., Scher, A. I., et al. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia, 27, 193-210. Trautmann, E., Lackschewitz, H., & Krner-Herwig, B. (2006). Psychological treatment of recurrent headache in children and adolescents - a meta-analysis. Cephalalgia, 26, 1411-1426. Yucha, C. B. (2002). Problems inherent in assessing biofeedback efficacy studies. Applied Psychophysiology and Biofeedback, 27, 99-106.  APPENDIX A List of studies included in the efficacy review (* Indexed studies are included in both meta-analyses for migraine and TTH) Allen, R.A., Mills, G.K. (1982). The effects of unilateral plethysmographic feedback of temporal artery activity during migraine head pain. Journal of Psychosomatic Research, 26(2):133-140. Andrasik, F., Blanchard, E.B., Neff, D.F., Rodichok, L.D. (1984). Biofeedback and relaxation training for chronic headache: a controlled comparison of booster treatments and regular contacts for long-term maintenance. Journal of Consulting and Clinical Psychology,52(4):609-615.  ADDIN EN.REFLIST Andrasik, F. & Holroyd, K. A. (1980). A test of specific and nonspecific effects in the biofeedback treatment of tension headache. Journal of Consulting and Clinical Psychology, 48(5), 575-586. Andrasik, F. & Holroyd, K. A. (1983). Specific and nonspecific effects in the biofeedback treatment of tension headache: 3-Year follow-up. Journal of Consulting and Clinical Psychology, 51(4), 634-636. Andreychuk, T., Skriver, C. (19175) Hypnosis and biofeedback in the treatment of migraine headache. International Journal of Clinlinical and Experimental Hypnosis, 23(3):172-183. Arena, J. G., Bruno, G. M., Hannah, S. L. & Meador, K. J. (1995). A comparison of frontal electromyographic biofeedback training, trapezius electromyographic biofeedback training, and progressive muscle relaxation therapy in the treatment of tension headache. Headache, 35(7), 411-419. Arena, J. G., Hannah, S. L., Bruno, G. M. & Meador, K. J. (1991). Electromyographic biofeedback training for tension headache in the elderly: A prospective study. Biofeedback and Self Regulation, 16(4), 379-390. Arndorfer, R. E. & Allen, K. D. (2001). Extending the efficacy of a thermal biofeedback treatment package to the management of tension-type headaches in children. Headache, 41, 183-192. Bild, R., & Adams, H.E. (1980). Modification of migraine headaches by cephalic blood volume pulse and EMG biofeedback. Journal of Consulting and Clinical Psychology, 48(1):51-57. Billings, R. F., Thomas, M. R., Rapp, M. S., Reyes, E. & Leith, M. (1984). Differential efficacy of biofeedback in headache. Headache, 24(4), 211-215. Bischoff, C. & Dahlinger, E. (1993). Behandlung von Spannungskopfschmerz mit EMG -Biofeedback im Feld--ein Effizienzvergleich mit traditionellem EMG-Biofeedback. [Treatment of tension-type headache with EMG-feedback in the field- Comparative efficacy to traditional EMG-feedback.] Verhaltenstherapie, 3(4), 286-295. *Blanchard, E.B., Andrasik, F., Neff, D.F., Arena, J.G., Ahles, T.A., Jurish, S.E., Pallmeyer, T.P., Saunders, N.L., & Teders, S.J. (1982a). Biofeedback and relaxation training with three kinds of headache: Treatment effects and their prediction. Journal of Consulting and Clinical Psychology, 50(4):562-575. *Blanchard, E.B., Andrasik, F., Neff, D.F., Teders, S.J., Pallmeyer, T.P., Arena, J.G., Jurish, S.E., Saunders, N.L., Ahles, T.A., & Rodichok, L.D. (1982b). Sequential comparisons of relaxation training and biofeedback in the treatment of three kinds of chronic headache or, the machines may be necessary some of the time. Behavior Research and Therapy, 20(5):469-481. Blanchard, E. B., Appelbaum, K. A., Guarnieri, P. & Morrill, B. (1987). Five year prospective follow-up on the treatment of chronic headache with biofeedback and/or relaxation. Headache, 27(10), 580-583. Blanchard, E.B., Appelbaum, K.A., Guarnieri, P., Neff, D.F., Andrasik, F., Jaccard, J., & Barron, K.D. (1988). Two studies of the long-term follow-up of minimal therapist contact treatments of vascular and tension headache. Journal of Consulting and Clinical Psychology, 56(3):427-432. Blanchard, E.B., Appelbaum, K.A., Nicholson, N.L., Radnitz, C.L., Morrill, B., Michultka, D., Kirsch, C., Hillhouse, J., & Dentinger, M.P. (1990a). A controlled evaluation of the addition of cognitive therapy to a home-based biofeedback and relaxation treatment of vascular headache. Headache, 30(6):371-376. Blanchard, E.B., Appelbaum, K.A., Radnitz, C.L., Morrill, B., Michultka, D., Kirsch, C., Guarnieri, P., Hillhouse, J., Evans, D.D., & Jaccard, J. (1990b). A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. Journal of Consulting and Clinical Psychology, 58(2):216-224. Blanchard, E.B., Dale, E.T., Williamson, D.A., Silver, B.V., & Brown, D.A. (1978). Temperature biofeedback in the treatment of migraine headaches: A controlled evaluation. Archives of General Psychiatry, 35(5):581-588. Blanchard, E.B., & Kim, M. (2005). The effect of the definition of menstrually-related headache on the response to biofeedback treatment. Applied Psychophysiology and Biofeedback, 30(1):53-63. Blanchard, E.B., Kim, M., Herman, N.C., Steffek, B.D., Nicholson, N.I., & Taylor, A.E. (1994). The role of perception of success in the thermal biofeedback treatment of vascular headache. Headache Quarterly, 5(4):231-236. Blanchard, E.B., Nicholson, N.L., Radnitz, C.L., Steffek, B.D., Appelbaum, K.A., & Dentonger, M.P. (1991). The role of home practice in thermal biofeedback. Journal of Consulting and Clinical Psychology, 59(4):507-512. Blanchard, E.B., Peters, M.L., Hermann, C., Turner, S.M., Buckley, T.C., Barton, K., & Dentinger, M.P. (1997). Direction of temperature control in the thermal biofeedback treatment of vascular headache. Applied Psychophysiology and Biofeedback, 22(4):227-245. Borgeat, F., Elie, R. & Castonguay, L. G. (1991). Muscular response to the therapist and symptomatic improvement during biofeedback for tension headache. Biofeedback and Self Regulation, 16(2), 147 -155. Borgeat, F., Elie, R. & Larouche, L. M. (1985). Pain response to voluntary muscle tension increases and biofeedback efficacy in tension headache. Headache, 25(7), 387-391. Borgeat, F., Hade, B., Larouche, L. M. & Gauthier, B. (1984). Psychophysiological effects of therapist's active presence during biofeedback as a simple psychotherapeutic situation. Psychiatric Journal of the University of Ottawa, 9(3), 132-137. Bruhn, P., Olesen, J. & Melgaard, B. (1979). Controlled trial of EMG feedback in muscle contraction headache. Annals of Neurology, 6(1), 34 -36. Budzynski, T. H., Stoyva, J. M., Adler, C. S. & Mullaney, D. J. (1973). EMG biofeedback and tension headache: A controlled outcome study. Psychosomatic Medicine, 35(6), 484-496. Bussone, G., Grazzi, L., D'Amico, D., Leone, M. & Andrasik, F. (1998). Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia, 18(7), 463-467. Chesney, M. A. & Shelton, J. L. (1976). A comparison of muscle relaxation and electromyogram biofeedback treatments for muscle contraction headache. Journal of Behavior Therapy and Experimental Psychiatry, 7(3), 221-225. Claghorn, J.L., Mathew, R.J., Largen, J.W., & Meyer, J.S. (1981). Directional effects of skin temperature self-regulation on regional cerebral blood flow in normal subjects and migraine patients. American Journal of Psychiatry, 138(9):1182-1187. Cohen, M.J., McArthur, D.L., & Rickles, W.H. (1980). Comparison of four biofeedback treatments for migraine headache: Psychological and headache variables. Psychosomatic Medicine, 42(5):463-480. Collet, L., Cottraux, J. & Juenet, C. (1986). GSR feedback and Schultz relaxation in tension headaches: A comparative study. Pain, 25(2), 205-213. Cott, A., Goldmann, J. A., Pavloski, R. P., Kirschberg, G. J. & Fabich, M. (1981). The long-term therapeutic significance of the addition of electromyographic biofeedback to relaxation training in the treatment of tension headaches. Behavior Therapy, 12(4), 556-559. Cox, D. J., Freundlich, A. & Meyer, R. G. (1975). Differential effectiveness of electromyographic feedback, verbal relaxation instructions, and placebo medication with tension headaches. Journal of Consulting and Clinical Psychology, 43(6), 892 -898. *Daly, E. J., Donn, P. A., Galliher, M. J. & Zimmerman, J. S. (1983). Biofeedback applications to migraine and tension headaches: A double-blinded outcome study. Biofeedback and Self Regulation, 8(1), 135-152. Epstein, L. H. & Abel, G. G. (1977). An analysis of biofeedback training effects for tension headache patients. Behavior Therapy, 8(1), 37-47. French DJ, Gauthier JG, Roberge C, Bouchard S, Nouwen A. (1997). Self-efficacy in the thermal biofeedback treatment of migraine sufferers. Behavior Therapy, 28(1):109-125. Friar, L.R., & Beatty, J. (1976). Migraine: Management by trained control of vasoconstriction. Journal of Consulting and Clinical Psychology, 44(1):46-53. Gada, M. T. (1984). A comparative study of efficacy of EMG bio-feedback and progressive muscular relaxation in tension headache. Indian Journal of Psychiatry, 26(2), 121-127. Gauthier, J., Bois, R., Allaire, D., & Drolet, M. (1981). Evaluation of skin temperature biofeedback training at two different sites for migraine. Journal of Behavioral Meddicine, 4(4):407-419. Gauthier, J., Cote, G., & French, D. (1994). The role of home practice in the thermal biofeedback treatment of migraine headache. Journal of Consulting and Clinical Psychology, 62(1):180-184. Gauthier, J., Doyon, J., Lacroix, R., & Drolet, M. (1983). Blood volume pulse biofeedback in the treatment of migraine headache: a controlled evaluation. Biofeedback and Self Regulation, 8(3):427-442. Gauthier, J., Fradet, C., & Roberge, C. (1988). The differential effects of biofeedback in the treatment of classical and common migraine. Headache, 28(1):39-46. Gauthier, J., Lacroix, R., Cote, A., Doyon, J., & Drolet, M. (1985). Biofeedback control of migraine headaches: A comparison of two approaches. Biofeedback and Self Regulation, 10(2):139-159. Gauthier, J., & Carrier, S. (1991). Long-term effects of biofeedback on migraine headache: a prospective follow -up study. Headache, 31(9):605-612. Gauthier, J., Fournier, A.L., & Roberge, C. (1991). The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine. Headache, 31(2):82-90. Gray, C. L., Lyle, R. C., McGuire, R. J. & Peck, D. F. (1980). Electrode placement, EMG feedback, and relaxation for tension headaches. Behaviour Research and Therapy, 18(1), 19-23. Grazzi, L., Andrasik, F., D'Amico, D., Leone, M., Moschiano, F. & Bussone, G. (2001). Electromyographic biofeedback-assisted relaxation training in juvenile episodic tension-type headache: clinical outcome at three-year follow-up. Cephalalgia, 21(8), 798-803. *Grazzi, L., & Bussone, G. (1993a). Effect of biofeedback treatment on sympathetic function in common migraine and tension-type headache. Cephalalgia, 13(3):197-200. Grazzi, L., & Bussone, G. (1993b). Italian experience of electromyographic-biofeedback treatment of episodic common migraine: preliminary results. Headache, 33(8):439-441. Grazzi, L., D'Amico, D. & Bussone, G. (1992). Italian experience of electromyographic-biofeedback for tension headache: Clinical results and one-year follow-up. Headache Quarterly, 3(4), 421-425. Grazzi, L., Frediani, F., Zappacosta, B., Boiardi, A. & et al. (1988). Psychological assessment in tension headache before and after biofeedback treatment. Headache, 28(5), 337-338. Grazzi, L., Leone, M., Frediani, F. & Bussone, G. (1990). A therapeutic alternative for tension headache in children: Treatment and 1-year follow-up results. Biofeedback and Self Regulation, 15(1), 1-6. Hart, J. D. & Cichanski, K. A. (1981). A comparsion of frontal EMG Biofeedback and Neck EMG Biofeedback in the treatment of muscle contraction headache. Biofeedback and Self Regulation, 6(1), 63-74. Haynes, S. N., Griffin, P., Mooney, D. & Parise, M. (1975). Electromyographic biofeedback and relaxation instructions in the treatment of muscle contraction headaches. Behavior Therapy, 6(5), 672-678. Heaton, G. (1979). Biofeedback in headache management: An evaluation of 56 patients. Journal Indiana State Medical Association, 72(3), 198-199. Hoffman, E. (1979). Autonomic, EEG and clinical changes in neurotic patients during EMG biofeedback training. Research Communications in Psychology, Psychiatry and Behavior, 4(3), 209-240. Holroyd, K. A., Andrasik, F. & Noble, J. (1980). A comparsion of EMG biofeedback and a credible pseudotherapy in treating tension headache. Journal of Behavioral Medicine, 3(1), 29-39. Holroyd, K. A. & Andrasik, F. (1982). Do the effects of cognitive therapy endure? A two-year follow-up of tension headache sufferers treated with cognitive therapy or biofeedback. Cognitive Therapy and Research, 6(3), 325-334. Holroyd, K. A., Andrasik, F. & Westbrook, T. (1977). Cognitive control of tension headache. Cognitive Therapy and Research, 1(2), 121-133. Holroyd, K. A., France, J.L., Cordingley, G.E., Rokicki, L.A., Kvaal, S.A., Lipchik, G.L., & McCool, H.R. (1995). Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. Journal of Consulting and Clinical Psychology, 63(2):327-330. Holroyd, K. A., Holm, J.E., Hursey, K.G., Penzien, D.B., Cordingley, G.E., & Theofanous, A. (1988). Recurrent vascular headache: Home-based behavioral treatment versus abortive pharmacological treatment. Journal of Consulting and Clinical Psychology, 56(2):218- 223. Holroyd, K. A., Holm, J.F., Penzien, D.B., Cordingley, G.E., Hursey, K.G., Martin, N.J., & Theofanous, A. (1989). Long-term maintenance of improvements achieved with (abortive) pharmacological and nonpharmacological treatments for migraine: preliminary findings. Biofeedback and Self Regulation, 14(4):301-308. Holroyd, K. A., Penzien, D. B., Hursey, K. G., Tobin, D. L., Rogers, L., Holm, J. E., Marcille, P. J., Hall, J. R. & Chila, A. G. (1984). Change mechanisms in EMG biofeedback training: Cognitive changes underlying improvements in tension headache. Journal of Consulting and Clinical Psychology, 52(6), 1039-1053. Hudzinski, L. G. (1983). Neck musculature and EMG biofeedback in treatment of muscle contraction headache. Headache, 23(2), 86-90. Hutchings, D. & Reinking, R. H. (1976). Tension headaches: What form of therapy is most effective? Biofeedback and Self Regulation, 1(2), 183-190. Ilacqua, G.E. (1994). Migraine headaches: coping efficacy of guided imagery training. Headache, 34(2):99-102. Janssen, K. (1983). Differential effectiveness of EMG-feedback versus combined EMG-feedback and relaxation instructions in the treatment of tension headache. Journal of Psychosomatic Research, 27(3), 243-253. Johansson, J. & Oest, L. G. (1985). Self-control procedures in biofeedback treatment of tension headache: The effect of "generalization training." Scandinavian Journal of Behaviour Therapy, 14(3), 99-112. Johansson, J., & Oest, L.G. (1987). Temperature-biofeedback treatment of migraine headache. Specific effects and the effects of "generalization training". Behavior Modification, 11(2):182-199. Jurish, S.E., Blanchard, E.B., Andrasik, F., Teders, S.J., Neff, D.F., & Arena, J.G. (1983). Home- versus clinic-based treatment of vascular headache. Journal of Consulting and Clinical Psychology, 51(5): 743-751. Kewman, D.M., & Roberts, A.H. (1980). Skin temperature biofeedback and migraine headaches. A double-blind study. Biofeedback and Self Regulation, (5):327-345. Kim, M., & Blanchard, E.B. (1992). Two studies of the non-pharmacological treatment of menstrually-related migraine headaches. Headache, 32(4):197-202. Knapp, T.W., & Florin, I. (1981). The treatment of migraine headache by training in vasoconstriction of the temporal artery and a cognitive stress-coping training. Behavior Analysis and Modification, 4(4):267-274. Kroener, B. (1982). Biofeedback als Interventionsverfahren bei chronischen Kopfschmerzen. (Biofeedback as an intervention procedure for chronic headaches.) Zeitschrift fuer Experimeltell und Angewandte Psychologie, 29(2):264-289. Kroener-Herwig, B., Mohn, U. & Pothmann, R. (1998). Comparison of biofeedback and relaxation in the treatment of pediatric headache and the influence of parent involvement on outcome. Applied Psychophysiology and Biofeedback, 23(3), 143-157. Kropp, P., Gerber, W.D., Keinath, S., Specht, A., Kopal, T., & Niederberger, U. (1997). Behavioral treatment in migraine. Cognitive-behavioral therapy and blood-volume-pulse biofeedback: A cross-over study with a two-year followup. Functional Neurology, 12(1):17-24. Lake, A., Rainey, J., & Papsdorf, J.D. (1979). Biofeedback and rational-emotive therapy in the management of migraine headache. Journal of Applied Behavior Analysis, 12(1):127-140. Largen, J.W., Mathew, R.J., Dobbins, K., & Claghorn, J.L. (1981). Specific and non-specific effects of skin temperature control in migraine management. Headache, 21(2):36-44. Lisspers, J., & Oest, L.G. (1990). Long-term follow-up of migraine treatment: do the effects remain up to six years? Behavior Research and Therapy, 28(4):313-322. Marcus, D.A., Scharff, L., Mercer, S., & Turk, D.C. (1998). Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia, 18(5):266-272. *Martin, P. R., Forsyth, M. R., & Reece, J. (2007). Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behavior Therapy. Vol, 38(4), 350-363. Mathew, A., Mishra, H. & Kumaraiah, V. (1987). Alpha feedback in the treatment of tension headache. Journal of Personality and Clinical Studies, 3(1), 17-22. McGrady, A., Wauquier, A., McNeil, A., & Gerard, G. (1994). Effect of biofeedback-assisted relaxation on migraine headache and changes in cerebral blood flow velocity in the middle cerebral artery. Headache, 34(7):424-428. Medina, J.L., Diamond, S., & Franklin, M.A. (1976). Biofeedback therapy for migraine. Headache, 16(3):115-118. Mizener, D., Thomas, M., & Billings, R.F. (1988). Cognitive changes of migraineurs receiving biofeedback training. Headache, 28(5):339-343. Mullinix, J.M., Norton, B.J., Hack, S., & Fishman, M.A. (1978). Skin temperature biofeedback and migraine. Headache, 17:242-244. *Neff, D. F., Blanchard, E. B. & Andrasik, F. (1983). The relationship between capacity for absorption and chronic headache patients' response to relaxation and biofeedback treatment. Biofeedback and Self Regulation, 8(1), 177-183. *Nicholson, N. L. & Blanchard, E. B. (1993). A controlled evaluation of behavioral treatment of chronic headache in the elderly. Behavior Therapy, 24(3), 395-408. Paiva, T., Nunes, J. S., Moreira, A., Santos, J., Teixeira, J. & Barbosa, A. (1982). Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache, 22(5), 216-220. Peck, C. L. & Kraft, G. H. (1977). Electromyographic biofeedback for pain related to muscle tension. A study of tension headache, back and jaw pain. Archives of Surgery, 112(7), 889-895. Philips, H. C. & Hunter, M. (1981). The treatment of tension headache: I. Muscular abnormality and biofeedback. Behaviour Research and Therapy, 19(6), 485-498. Reich, B. A. (1989). Non-invasive treatment of vascular and muscle contraction headache: A comparative longitudinal clinical study. Headache, 29(1), 34-41. Rokicki, L. A., Holroyd, K. A., France, C. R., Lipchik, G. L., France, J. L. & Kvaal, S. A. (1997). Change mechanisms associated with combined relaxation/EMG biofeedback training for chronic tension headache. Applied Psychophysiology and Biofeedback, 22(1), 21-41. Sargent, J., Solbach, P., Coyne, L., Spohn, H., & Segerson, J. (1986). Results of a controlled, experimental, outcome study of nondrug treatments for the control of migraine headaches. Journal of Behavioral Medicine, 9(3):291-323. Schoenen, J., Gerard, P., de Pasqua, V. & Juprelle, M. (1991). EMG activity in pericranial muscles during postural variation and mental activity in healthy volunteers and patients with chronic tension type headache. Headache, 31(5), 321-324. Sethi, B. B., Trivedi, J. K. & Anand, R. (1981). A comparative Study of relative Effectiveness of Biofeedback and Shavasana (Yoga) in Tension Headache. Indian Journal of Psychiatry, 23(2), 109-114. Silver, B.V., Blanchard, E.B., Williamson, D.A., Dale, E.T., & Brown, D.A. (1979). Temperature biofeedback and relaxation training in the treatment of migraine headaches: One-year follow-up. Applied Biofeedback and Self Regulation, 4:359-366. Sorbi, M., & Tellegen, B. (1984). Multimodal migraine treatment: does thermal feedback add to the outcome? Headache, 24(5):249-255. Steger, J. C. & Harper, R. G. (1980). Comprehensive biofeedback versus self-monitored relaxation in the treatment of tension headache. Headache, 20(3), 137-142. ADDIN EN.REFLIST  Turin, A., & Johnson, W.G. (1976). Biofeedback therapy for migraine headaches. Archives of General Psychiatry, 33(4):517-519. Vasudeva, S., Claggett, A.L., Tietjen, G.E., & McGrady, A.V. (2003). Biofeedback-assisted relaxation in migraine headache: relationship to cerebral blood flow velocity in the middle cerebral artery. Headache, 43(3):245-250. Wauquier, A., McGrady, A., Aloe, L., Klausner, T., & Collins, B. (1995). Changes in cerebral blood flow velocity associated with biofeedback-assisted relaxation treatment of migraine headaches are specific for the middle cerebral artery. Headache, 35(6):358-362.  APPENDIX B Study Coding and Validity Assessment Scale Identification: identification number, coder, author, country, publishing journal, year of publication; Methodology: design, number of BFB and control groups, measurement points, type of outcome variables, use of a structured headache diary, number of weeks of diary assessment at pre, post and follow-up measurement, number of participants, number of dropouts, research hypothesis, statistical data for the calculation of effect sizes; Subjects: diagnosis, diagnostic instruments, additional diagnostic information, patient characteristics (age, years with headache, gender); Treatment: type of biofeedback intervention, additional relaxation training during biofeedback, feedback modality, type of control intervention, treatment setting, treatment documentation (number and duration of sessions, treatment manual), changes in medication. Internal validity: design, treatment allocation, dropout, type of outcome variables; External validity: time points, patient characteristics; Construct validity: treatment documentation, diagnose, medication status, blinding; Statistical conclusion validity: number of participants, statistics for effect size calculation. Author Note This paper was prepared as a White Paper review, according to the template guidelines developed by the Association for Applied Psychophysiology and Biofeedback (AAPB) and the International Society for Neurofeedback and Research (ISNR). All authors declare no conflicts of interest. Correspondence should be addressed to Yvonne Nestoriuc, Ph.D. Brigham and Womens Hospital, Department of Psychiatry, Harvard Medical School, 1620 Tretmont Street, Boston, MA, 02120, USA Phone: (011) 617 732 5969, Fax: (001) 617 278 6907, E-mail:  HYPERLINK "mailto:ynestoriuc@partners.org" ynestoriuc@partners.org Co-authors affiliation: Prof. Dr. Alexandra Martin University Erlangen-Nrnberg, Department of Psychosomatic Medicine and Psychotherapy Schwabachanlage 6, 91054 Erlangen, Germany Phone: 0049 9131 85-44699 Fax: 0049 9131 85-35952 E-mail: alexandra.martin@uk-erlangen.de Prof. Dr. Winfried Rief Philipps-University of Marburg, Section for Clinical Psychology and Psychotherapy Gutenbergstr. 18, 35032 Marburg, Germany Phone: 0049 6421 2823657 Fax: 0049 6421 2828904 E-mail:  HYPERLINK "mailto:yvonne.nestoriuc@staff.uni-marburg.de" rief@staff.uni-marburg.de Prof. Dr. Frank Andrasik University of West Florida, Department of Psychology 11000 University Parkway Pensacola, FL 32514, USA Phone: +1-850-474-3298 Fax: +1-850-857-6060 E-mail: fandrasik@uwf.edu Table 1 Characteristics of the integrated studies: demographics, diagnosis, treatment, validity MigraineTTHCharacteristicnDescriptive statisticsnDescriptive statisticsTotal number of patients562266451289 Age, mean (range)4637.2 (28-67)3837.9 (20-67) Sex (% female, mean + range)4688.4 (21.2-100)3872.7 (42.9-100) Years since diagnose, mean (range)3217.1 (8.5-37.6)2714.8 (3.0-42.4)Use of standardized diagnostic system, %4580.42351.0 Unstandardized exam (characteristic features)47.21534.1 Diagnose adopted from preceding medical exam712.7715.9Dropout after treatment assignment, %4314.3289.3 Dropout at follow-up, %114.7815.1Duration of follow-up in month, mean (range)1614.3 (6-60)1714.0 (3-60)Feedback modalities, number of treatment groups56854551 EMG-FB840 EMG-FB + relaxation/TEMP-FB357 TEMP-BF192 BVP-FB16- EEG-FB31 Galvanic skin response feedback41Number of sessions, mean (range)5610.8 (3-24)4511.2 (6-20)Duration of sessions in minutes, mean (range)4543.5 (20-95)4142.6 (20-90)Description of a treatment manual, %4478.63680.0Control conditions, number of groups40352838  Waiting list158 Placebo128 Relaxation514 Pharmacotherapy23 CBT /Stress management13 Physical treatment-2Patient blinding, % calculated from controlled studies1025.6622.2Studies with e" 2 outcome categories , %4783.93168.9Outcome depicted in means and standard deviations, %4173.22146.7Note. Numbers are frequencies unless described otherwise. n = number of studies, TTH = tension-type headache, EEG-FB = Electroencephalographic feedback, EMG/FB = Electromyographic feedback, TEMP-FB = peripheral temperature feedback, RT = Relaxation training, BVP-FB = Blood-volume pulse feedback, CBT = cognitive behavioral therapy. Table 2 Mean weighted effect sizes for headache reduction through biofeedback in different treatment comparisons MigraineTTHComparisonkNEffect Size (95% CI)kNEffect Size (95% CI)BFB vs. no treatment control155910.46 (0.27, 0.64)81470.79 (0.40, 1.17)BFB vs. placebo control123400.25 (0.00, 0.49)81350.50 (0.26, 0.75)BFB vs. Relaxation51360.10 (-0.39, 0.50)143960.18 (0.06, 0.30) Note. BFB = biofeedback, Placebo = non-pharmacological placebo treatment (e. g., pseudo/sham feedback, finger cooling), TTH = tension type headache, k = number of effect sizes, N = number of headache patients, Effect Size = weighted mean effect size, 95% CI = confidence interval for mean effect size. Table 3 Mean weighted effect sizes for headache reduction through biofeedback at post-treatment and follow-up in completer and intention-to-treat analyses MigraineTTHComparisonkNEffect Size (95% CI)kNEffect Size (95% CI)Pre vs. post-treatment (Completer)8514890.58 (0.52, 0.65)496580.70 (0.57 0.83)Pre vs. post-treatment (ITT)8517290.53 (0.45, 0.60)497120.59 (0.49, 0.70)Pre-treatment vs. follow-up (Completer)254750.67 (0.55, 0.79)172360.45 (0.28, 0.61)Pre-treatment vs. follow-up (ITT)255030.65 (0.47, 0.81)173130.31 (0.11, 0.45) Note. BFB = biofeedback, TTH = tension type headache, k = number of effect sizes, N = number of headache patients, Effect Size = weighted mean effect size, 95% CI = confidence interval for mean effect size, ITT = intention-to-treat analysis. For ITT dropouts were considered as nonresponders and replaced with zero effects. Mean duration of follow-up for migraine studies is 14.3 (SD = 14.2) months, for TTH studies 14.0 (SD = 16.1) months.  Figure 1 Mean weighted effect sizes for the different feedback modalities in the treatment of migraine. Outcome is measured in headache pain. Mean effect sized are displayed with their individual 95% confidence intervals (k = number of independent effect sizes). EEG-FB = Electroencephalographic feedback, EMG/FB = Electromyographic feedback, TEMP-FB = peripheral temperature feedback, RT = Relaxation training, BVP-FB = Blood-volume pulse feedback.  Figure 2a Mean weighted effect sizes for the different outcome variables in the biofeedback treatment of migraine. Outcome is measured in headache pain over all biofeedback modalities. Mean effect sizes are displayed with their individual 95% confidence intervals (k = number of independent effect sizes).  Figure 2b Mean weighted effect sizes for the different outcome variables in EMG-FB for tension-type headache. Outcome is measured in headache pain. Mean effect sizes are displayed with their individual 95% confidence intervals (k = number of independent effect sizes). EMG micV = reduction in muscle tension measured in microvolts through surface electromyography.   Studies with children and adolescents resulted in a significantly different average effect size (see Nestoriuc, Rief, & Martin, 2008) and were therefore excluded from further analyses in this review. Hence, all results presented in this white paper review apply to adult headache patients.  Average effect sizes from .2 to .5 are considered small effects, average eff</ 0 1 2 V W ) *  _ ` |qeqjh\vUmH sH h/h\vmH sH #h\v0JB*CJaJmH phsH +h\vB*CJOJQJ^JaJmH phsH h\vB*CJaJmH phsH h\vCJaJmH sH h\vCJaJmH sH h\vCJH*aJmH sH  h\vH*h\vh\v5mH sH h\v5CJaJmH sH h\vmH sH ";<=0 * + , - S t  C d$da$ $ p#da$  p#d 9<\mNUyzno|}  4#5#K#L###&&5&6&,,22?3@333664656ûûûûhXbmH sH h\vmH sH h\vmH sH h\v6mH sH h/h\vmH sH h/h\v0JmH sH jh\vUmH sH jh\vUmH sH C ;N#+;?]iiiiiipq"v~www"G*`d`d` $d`a$d5666P9Q9e9f9(:+:;;<<JJ$K%K]K^KMMMMMM|Q}QQQQQ=T>TZT[TTTWWWW@XAXZZ[[[[]]bbbbMdNdggggii jjj'm(m.m/mMmNmJoKoQoRoppqh\v6mH sH h)emH sH h\vB*mH phfsH h HpmH sH jh\vUmH sH h\vmH sH Nqqvrwrtttt#voz%&,-GHNO#$BCe+,v#%]mnoYZno,-&' $%shNYmH sH jh\vUmH sH h\v6mH sH hXmH sH h\v6mH sH h\vmH sH h\vmH sH jh\vUmH sH G e#$%n6 ~" $ $$$$%$0d^`0a$ 0d^`0 d7$8$H$`dd` jd`    H Uhi^_34fz!{!!!)#0#y## $ $$$$,$-$$$$ %%&&&&&&&··h/h\v56mH sH h/h\v6mH sH hU+h\v6mH sH hU+h\vmH sH jhU+h\vUmH sH h\v6mH sH h\vmH sH jh\vUmH sH h\vmH sH h\v6mH sH 7%(&&'f(():*;**!,--../H011R2t3<455o6$#d^#`a$ 0d^`0$0d^`0a$&&l''D(X(((([))))*&*;*s***Q+!,,,----m.{...t//80@000111152D2222=3i3%4144455R6S6Z6f666u777긭hU+hU+mH sH hU+h\vmH sH hU+h\v6mH sH hU+h\vH*mH sH  hU+h\v h/h\vhU+h\v6mH sH hU+h\vmH sH h/h\vmH sH >o667X89:;I<<[==>s?)@@@@@;AACCDcEF 0^`0d$0d^`0a$ 0d^`07768J899::x;;;<8<<<+=P=[====N>p>>>Y?h?s?? @@{@@@@@;A\AAABCCC#C$CCCCCqDDEREgFwFFF$Gjh\v6UmH sH h\vh\v6mH sH h\vmH sH jhU+h\vUmH sH h/h\vmH sH  hU+h\vhU+h\v6hU+h\v6mH sH hU+h\vmH sH h)emH sH :$GKGTGUG}GGHHH>IPIXIYI~IIrJJJJKK M*MMMNNNOAPJPQQmRRRR&SOST,TTTUU VVVxWWWWFX~XXXXXYYYYYYYZZZ0[q[>\\\ ]"]3]a]]]^^^h\vmHsHh/h\v6mH sH h\vh/h\vmH sH h\vmH sH h\v6mH sH PFUGHHYIJK;MN%OZPQR]S;TUVVWXYYZz[p\3]]^_ 0^`0^^___m````` a&afanaaaaa8bgbbbc"c#c]cccgdd?e`eefUfffKgTgghhhiiiiTj_jk kkJkkkkkkl|llǼǴ㫴h\v6mHsHh\vmHsHh\v6mH sH h\vmH sH h/h\vmH sH h/h\v6mH sH hRmH sH hU+mH sH h\vmH sH h/h\vmH sH h\v6mH sH <_`-aatb#ccdneffdghhipjkklam(nno>ppqer|st 0^`0lll3m\mammm!n'n(nnnnnFooo5p=p>popppppqqqqqr6r\r>smsHtwtuuvvvvbwrwywzwwx x xcxkxyCyKyLyyzzzq{{!|A|||}}}Y~~~Z[} h\v6h\v h/h\vh/h\v6h/h\vmH sH h\v6mH sH h\vmH sH Ptuvzw x{xLyzz{O||}~U{@ބ,9!Ĉ 0^`0} Ey_j2ք܄ބ#+ !q=EF݊i{RDbI[bd!ǐ(9ABTUjh\vUmH sH h\vmHsHh\v6mHsHh/h\vmH sH h\vmH sH h\v6mH sH NFrd*Vԑʓ˓̓FdEƀ%f 0^`0̓_k8B@RΗ"B<ӚԚ՚iʜ˜ "HIWXôyyh\v5CJaJmH sH h\vCJaJmH sH h\v0J>*B*phjh\vUh\vh\v0JmH sH jh\vUmH sH h\vmH sH jh\v6UmH sH h\v5mH sH jh\vUmH sH h\vmH sH h\v6mH sH /@<i#iœ!";pdh d7$8$H$ 0^`0dpΝHIRSW$ t"@8Bcdh$If]ca$ t"@8Bdh$If]$ t"@8Bdh$If]a$ 0t"@8Bdh$If]dh WXgi`J) $ t"@8Brdh$If]^`ra$ ht"@8Bdh$If]kd$$IfF\lm( 2  t0 )44 lai$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$8% dh$If]kd$$IfF ֈl"m* (_u t0 )44 laŞ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$Şƞٞ:) dh$If]kd $$IfFֈl"m* (_u t0 )44 laٞܞ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la,-0@$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$@Ae:) dh$If]kd$$IfFֈl"m* (_u t0 )44 laehxy|$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$IfFֈl"m* (_u t0 )44 laŸǟ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$ǟȟ:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$5:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la57<=?D$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$DEk:) dh$If]kd $$IfFֈl"m* (_u t0 )44 laknstw{$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra${|:) dh$If]kd $$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$Ҡ:) dh$If]kd $$IfFֈl"m* (_u t0 )44 laҠՠ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$":) dh$If]kd $$IfFֈl"m* (_u t0 )44 la"%(),/$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$/08:) dh$If]kdp $$IfFֈl"m* (_u t0 )44 la89;<=@$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$@A^:) dh$If]kd]$$IfFֈl"m* (_u t0 )44 la^_bcdf$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$fgp:) dh$If]kdJ$$IfFֈl"m* (_u t0 )44 lapqtuvx$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$xy:) dh$If]kd7$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la¡$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$¡á:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$2:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la25BCFS$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$STy:) dh$If]kd$$IfFֈl"m* (_u t0 )44 lay|$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$͢:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la͢΢ѢҢӢբ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$բ֢ߢ:) dh$If]kd$$IfFֈl"m* (_u t0 )44 laߢ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kd$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$:) dh$If]kdy$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$.:) dh$If]kdf$$IfFֈl"m* (_u t0 )44 la./1235$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$56J:) dh$If]kdS$$IfFֈl"m* (_u t0 )44 laJKMNOQ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$QR:) dh$If]kd@$$IfFֈl"m* (_u t0 )44 la$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$P:) dh$If]kd-$$IfFֈl"m* (_u t0 )44 laPV`bhr$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$rtޤ:) dh$If]kd$$IfFֈl"m* (_u t0 )44 laޤ$ t"@8Bcdh$If]ca$$ t"@8Bdh$If]a$$ t"@8Bdh$If]a$ $ t"@8Brdh$If]^`ra$ΦϦئ:83& $6Bxdh]xdhkd$$IfFֈl"m* (_u t0 )44 la Ϧئ@ABPQ34sx #%nt?@AOP!"<>pqs|ֹֹޫ֟֓֋hRmH sH jV h\vUmH sH jߖh\vUmH sH j,h\v5UmH sH h\vCJaJmH sH h\v6mH sH hU+mH sH h\vmH sH h\v5mH sH h\v6CJaJmH sH h\vCJaJmH sH 6ئABKLP$ t"@8Bdh$If]a$ t"@8Bdh$If] $6Bxdh]xPQ\^`uvxz`LLLLLLL t"@8Bdh$If]kd$$IfF\u =3 < t0344 laz t"@8Bdh$If]kd !$$IfFִu e#'=3 h hA  t03    44 laƧǧɧͧߧ t"@8Bdh$If] dh$If]ߧkdz"$$IfFִu e#'=3 h hA  t03    44 la* t"@8Bdh$If] dh$If]*+kd#$$IfFִu e#'=3 h hA t03    44 la+>@DWX[_q t"@8Bdh$If] dh$If]qrkd$$$IfFִu e#'=3 h hA  t03    44 lars@AJKO$ t"@8Bdh$If]a$ t"@8Bdh$If] $6Bxdh]x t"L,@8B] t"L,@8Bdh] t"@8Bdh] OP[]_tuwy`LLLLLLL t"@8Bdh$If]kd%$$IfF\Vg#Z$7 t0_844 lay t"@8Bdh$If]kd&$$IfFִV&g#Z$J(,7*A hA  t0_8    44 la̪ͪЪԪ t"@8Bdh$If] dh$If]kdg($$IfFִV&g#Z$J(,7*A hA  t0_8    44 la !%7 t"@8Bdh$If] dh$If]78kd)$$IfFִV&g#Z$J(,7*A hA t0_8    44 la8`cgyz} t"@8Bdh$If] dh$If]kd*$$IfFִV&g#Z$J(,7*A hA t0_8    44 laϫЫӫ׫ t"@8Bdh$If] dh$If]kd+$$IfFִV&g#Z$J(,7*A hA  t0_8    44 lanoprs t"L,@8Bdh] 0*@H]H FGvwyz|}ʜ˜̜h]h&`#$$a$ !"#$EGHvwxz{}~ɜ͜ΜӜԜʹh\0JmHnHu h\v0Jjh\v0JUh\vjhwkjUhwkjUh\vmH sH jh\v0JUh\vmH sH 'ect sizes from .5 to .8 are considered medium and average effects over .8 are considered large effects (Cohen, 1988).     PAGE  PAGE 2 BIOFEEDBACK TREATMENT FOR HEADACHE DISORDERS ̜͜ΜϜМќҜӜԜ2 01h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% /1h;0. A!"#$% 21h0;0A .!"#$% 21h0;0A .!"#$% /1h;0. A!"#$% /1h;0. A!"#$% DyK ynestoriuc@partners.orgyK >mailto:ynestoriuc@partners.orgDyK ynestoriuc@partners.orgyK >mailto:ynestoriuc@partners.org$$If!vh55 552 #v#v #v#v2 :V F t0 ),55 552 / / / / / / C$$If!vh555_555u#v#v#v_#v#v#vu:V F  t0 ),555_555u/ / / / / / $$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u/ $$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh555_555u#v#v#v_#v#v#vu:V F t0 ),555_555u$$If!vh5 5<55#v #v<#v#v:V F t03,5 5<55/ / / / / / o$$If!vh5 55h5 555h5A #v #v#vh#v #v#v#vh#vA :V F t03,5 55h5 555h5A / / / / / / %$$If!vh5 55h5 555h5A #v #v#vh#v #v#v#vh#vA :V F t03,5 55h5 555h5A / $$If!vh5 55h5 555h5A #v #v#vh#v #v#v#vh#vA :V F t03,5 55h5 555h5A %$$If!vh5 55h5 555h5A #v #v#vh#v #v#v#vh#vA :V F t03,5 55h5 555h5A / $$If!vh5555#v#v#v#v:V F t0_8,5555/ / / / / / o$$If!vh555*5A 555h5A #v#v#v*#vA #v#v#vh#vA :V F t0_8,555*5A 555h5A / / / / / / %$$If!vh555*5A 555h5A #v#v#v*#vA #v#v#vh#vA :V F t0_8,555*5A 555h5A / $$If!vh555*5A 555h5A #v#v#v*#vA #v#v#vh#vA :V F t0_8,555*5A 555h5A $$If!vh555*5A 555h5A #v#v#v*#vA #v#v#vh#vA :V F t0_8,555*5A 555h5A %$$If!vh555*5A 555h5A #v#v#v*#vA #v#v#vh#vA :V F t0_8,555*5A 555h5A / iDd1FL  C (AFigure1RXir0 eB%)I8AG4i+-F,ir0 eB%)I8AGJFIF`` AppleMark    % #!,!#'(***.1-)1%)*(  (((((((((((((((((((((((((((((((((((((((((((((((((((  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzw!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzZO" ?F((((((((((((((((( MP|MĻ u6vNO8/!f?7I@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@߅9? :+I8N[*m9OXzmiX^YM"/v8o@9c3WeuzmIЉU)$x'pp[:V~}?CֵI-lu#?2J$jOqQWomoRO%ƁZiBpPj7Zeԯ"tP c  :}uǥEC.JthI4mo,Nk}Oǚ-$Eڈg*H%Ho<w??:Οy$>fn۸#8@3뤯;珼%f\j >(RKr7+ GjJ(((((w*P" ۞I_ݮ);&@?x– ωh'KH"VF(*Al6h2*qJ ٵksOCf(??w  ?b?ܾ>e(١*OCf(>rs.AEs;PT4?CQLGÙw: +6h2١*b?ܾ˹Q\'C?U;PT}S>0]΂?w  6h2꘏/2tW? leG'C?UTϹ}9sOCf(??w  #}a̻g_]\i.a|gaH5|6p>繙?uKi,*G܉7)^NfcGʸenRd=Qu8A>.rsOCf(??w  #}a̻4?CQ leG1_se(١*OCf(>rs.AEs;PT4?CQLGÙw: +6h2١*b?ܾ˹Q\'C?U;PT}S>0]΂?w  6h2꘏/2tW|Qms ukGǛKݴg55+,55$nZm~6Bc+Q^yaEPEPEPEPEPEPEPEPEPEPEPEPEP\ޣhĚfpܪʲZ"f ,8=%dkU cH3[]9c@dcЌ2v[v*O}7Yyq\2"Ϝܠ<р@2rxQ]?UBEԗd$^.3_猝:[ sLIeMF'%$j[xWQ?ۼ5}ϰƹ_FNp3@Z&֯l:{hW0E@w d˯k>%ǧꖒ4XGb~KYwJ4\[(hU,7dxsCӴ2Ft}˹v @G4?6y|߱Z>fݴ '@5}V dXWO%A> >pA:DZi2Oihwᥓ]dO]-2K r=!g@LlUf%r0ULky49 8Nu`+/$n%Qg4 sAk#@ۇCKge.H%IUU * :Sg`!%<~%^6j~L;Z)m-(CH&o _]=}иeK yq0mUv<+L-okSwgn/^t?ٶ>Gohocw뻞x2?٩kžZ(5';g?69`P$:)I>oF~-߷~8=]mcavva|1yuw6q֥+[XcH#P0@x{_5B=B= {FK%Ug#cnxo1_ FF[Vcq\\MD4e|>';Wޑw6~7V;wm8zdV>owk]ywQ[G\.( 00sofK45 %k6gT|x2JF m¨3z^}k+[6m*)mYP}]khѤV*YA(G:_4=Z6ߏZX߳yqb砠GFiڏwg-ZW ѭZ3pDK }Qún[êЯ%%α<_-okBp\vZ_4=Z6ߏZX߳yqb砨|'.O4;{4\Pa`[6[e>qd.`CIp9eE@VƗRQ-^ 얉%伤Q;q!OS6?"XF9E`Z`Ţ~BX imc_&%LE|]ͅ7u?x?nPmЯ=r?S[G OCl?MtQGÕv9@<B?w z ak??S[]}o?%]3G1md۹0?r|sɼ-mW::>q/$(:2= IXobipX}o:(z(Œ(5/5c5Kyaӕ?o^ލ>c\/5rUw z ah)->r?S[G OCl?MtQGÕv9@<B?w z ak??S[]}o?%]Ч&@<B(x/*sx;=4?AE[}9Wc)-Ч& (#~KaʻG@Ѵ?5lt;Wo-/3[v3g׸EoKF9-`wԘ;EWXQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE_C3o sMuPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPX|+^IcxGeQș0# ".|G<`F[Z"^jr[oZd[y9Oduޕ%~gx(@ Q)RwfPHHZk;V1q"4qJ`: '+|s%:ׇ{{]CA5 MvR(fDl qq;|Ox&ie4nRX#kXzr.Xd\V,֨t}KSWx͔w;`mNF8;,庺8-C$R5%d\^MW&At:ٯ^ɠH:y\O]R *+x^oak}{ϦC )+GG##k]^;7ĺ=ܹG$U85yq49&qQEB#dNgJ ۄ%drZ03OA9oks61gޕǡ9S_4 mM zVԬot1/*b>\t;N:V' =s 핅~ dQ9r0Fr u4Of$6h\^b»ېO$EH=5_xsA[]__ۇA"y{.Ifg7]=IF$jq--.6/;y<1\H諍PE2H2@6@: MJo-wC2)30~ml7CY[YJ|l!}m0$H٭%īFXl  ."_csڷ>Nݿ>a;}(Ha@8UR}Y])CS䃝I>F:|ۉrh{:]FQvղwf :y璄㎪Nr(:ub6_UxHPtDdI$IoRZ^>FA  _Qp|kvrCCj+Ii~oHQ$IOXt< o%p5+)GW:Wao\6M|F[ K2CSÝy +0D.o&L>#-ˆ2CSÝy +0D.o&L>#-ˆ2CSÝy +0D.o&L>#-ˆ2CSÝy +0D.o&L>#-ˆ2CSÝy +0D.o&L>#-ˆ2CSÝy jpMr<6\ȱX)b$ q+7m{q=r φcNImPhl N+Z9UYUe(Y/)BsVA𧉬cZk|Skwb\*rO~^/IfoQ-zr†.mI/D*.MQ\EQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s~ /}R Y'yl0E@"W;Qq" (6@%%k8fn@;3F$`qE77얾W]*9<J\E4Q^lhDT6۴%@( P6kZ}]y֗Ǹu* 2 ՚(ZχmmⴍuFKg.{% &&8(AR8#WSEdx@O~Hk-&`+Ur*0ۊ="Ϻl-ޡe[к/| Ҍr:EGmn[dd)Fs,ԒIMEue=[屘nۈ7?$0r9P Y1/)5izĘaY_縔22/u\Ϟ.[n(jQEQEQEQEQEQESzguw\A {vFN#lQWNnWV8i:Nok;͋z;Tx`x=밢^Xӭ=vQEŠ(((((((((((((((((((((((oc}t_C3o ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( uۿokhgu -b3 !p;1]bk}66!O?<02y@Md-ߌn5-[C{}f4ܨ l /R$:I}sVUΨ~[kWX,Yd+K!fBπN A$7>2ԵSi.kUC- ĨFD򠃏j? [^Gg=: ZiobT7$.}Q|Y=?KhKs;LQKDA:ĶWxPHեJLK)`9COJ4?kvSWz}ymO">{XܱbHC*NHf7G>o+í[-2\".9`4V}ºޯjƟu FdpEGx+Rt{A2+m&Xdn0rsN@#fzQjR:etjȌ+,Hgh.`ki^pZF68]J2ǰJ^1 }ơ̓ 2*dv9 |#S>SOe_ GX>2~>yG [Bw-|"m&zrD\1mު_OH|#s,\&uiECmbRrFqmOmZ~qfni{=S nvYXrHd4#넔Gz2$gdu ASTMjE4/My 2/,UweԳ^ٽכ<ʪdzoI$IM*By/!4dR,7p#v1 fK{d\\xfZ{TeUwHēBC.`|tO Omrb4^a B$O$i"Z{a[صX9 \qw xio#"Xoۻ2;zPx1κJoëW\x{|V:AnmHGs''tWPEPEPEPEPEPEPEPEPEPEPEPEPEP_]|5 [Vn>}oRWۺdS G#lxBT𞇨^I]&лVc2Iq\O%DU?oy mѧ[[j"tjvFp`},>yTgRJ/I^mrM5o˱4W¦?9(MSsW%e^]@7O9aG*osJz ?S}_?Vc(?MSsQ ?Ey*osT??W15KF8=dnnԐxm|Ir,V61'x j2L` x2ۃ[TԵ'bno3Ohs»p%XmAo"rL-h缶kvkRX"9WR2r+þ%#qIxz"ZmAt$d$/c pTkJQlRWW¦?9(MSsW?%cEy*osT??W +S¦?9(/.ǠQ^ 7O9aG%ayv+^ j.^H8 7=yH?D?/')–eZI= n +4 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (#+[XcH#P0@%PEPkmIt.$E7bORw v}MIE_C3o sMuPEPEPEPEPEPEPEPEPEPEPEPEPEP?3gB%+[ݕ\muq;t>V#com!8QZjݽ++(aEPEPEPEPw-1c)2# y>uG `U\ZbGv ,+4WfBtͥ5gm%6 ( ( ( ( (9xM6Ow<\55۫0bAֺJ(kV^UOv$VAEVC ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (9 sMuW7x1κJ(((((((((((((((((((((((k^Ҽ;jL,]dN$hU8IEI_@ (((((((((((((((Xv֋u!յ9 %Ĭ)k<4J2Ŏ3kgJQ|?uƩju0rAe6ҩ n 'hī}2xe}:.ICAcac9'&=w2:h~+Huki[Eg4BE-ɜw/|Gg_H4kV[BKg`0"q}Rɧ뚽΅yZ2際+m'a(m1s(mFxw@h㳑jE/ T<C¸7Ƃ_jN#t'7.AN>M ]N}=8#qu&'t c%||njI=*}º&tƟk+DIFdT$2G]BHo5+|=2x$cLpAdxfNuE]?\"xQ'Ӥ wsaW^A=pl_"_j}ͪSU ;"Hq]MxޙA?J& qYdUnȐLe* %g%yoci<ˋV8$b }Hþ1o໭?C#I-Vgu_'2FC>`znk(🎴?,ai5›[{ԚO*)%08rx'Ğ WZnE"-gͲwd9>3]AZkn:IuqtLigi֫[iSKWgiᢒ嘑`=87xQ鑹{HxUWBG#ی&<ϓ'/v-NpͅqĢ [nAPg+MGu'MbukoDŌ(H۝λtK4?{Tդ:õۭyS" ⻎Et>#U毤Xw}-%pĀH8>d^BԭttMd6069G\6;Y4q"闐Iov*pZJ_WAaTbgK?ŪCͽ-fDސ|{l9_,] z,qFO՚MNK(G rիnN4]}>.%,JQbò**H1€tmKR]ֳyНRL ^w-z6ZPWI]7-'XaADf?>;X&TD @C'>o5gzTtM"{?OV*Hd #~"niovcTV6c墐9fȮjHom|=3획c[DpCc=#J՝[yuB\0 Հ I=*τ_>9nt%RyA A<3zST5m^ԭ¶}}6 ,rZT1,ۂfkkr)Xtu$* rcaMze\Y-ԋ-ԏnv~h^$D`(+[Rm~PQA,~uiq)EVFv`Zڅ'4FKQq!R%#>P|¹3XxzѵMR.}CL>-ՍQHas/k&B)n4gHK%GyoKzِ+,i L:#IlPiX&ЬmN}ܭ540ﹸ3b*T.5k[+Ǻ4O>_% U=;F.C+8\kj,pE8]2ϱZK|7Ꚏ~RVR X$%݌ <:9\-֯iz egUqh|+/$Ѧt7BvyOz֊Hj7m|}Wu @Vem,Ѳ{V8 t?>3d}'_G!?ϰo~_)fmXʸV^Rd=u8>=g/K+ W>{$Y }OR͡C*Qoeos{~>~}7=١*OCf(?w z ah)-?;)'C?U;PT?S[G'%2ZmfOyu' {ؤvV$~ȉZ蕮/<56o4iVwQ'7\8ePFA#kEZ1>"׿,{5tQE|QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE_C3o sMuPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPT=M֠[mWN W,Wp,sW(fETQEQE h>)ޗئA[㪜 ʜ [QW*T$Ke_{v(QE^O-d- ญdFeXp@?QR[iV8P8%\往QEHQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@}f}Iewumk2aFiY±2pd[C4͆+ Yi &XapJ$Ŀ=>O#ɋO1ULowE .k6^*M֑^:̱L bjrc's@mGD`״m?WIP%ꮡ` gt$tU<pS8<%G}SO 3$ *$Ta rztD7%;Fk7GGSTƶ:WM'P,?+/L*66Xh UzeiV3\wtQ4j:!ݺh6đYM.MCK/.-VeCQ$ic$'>^9 sMuW7x1κJ(((((((((((((((((((((o9|ͪP]7 lvX* +0wF Ui-ГM]QY ((((_>ҾPq.VpQGR@:NcGͷenQfA z^._װآ+aEPEPEPE:o4u]V mmYfe5+T+J(aEPEPEPEPEPEPEPEPEPEPEPEPEP-xYo&E,$lRVF/d"|+J=ׇ!7;uԶ-D䪛ϔ:Z'vt5z% ^(K#Ɠ^k6mt$Ylmm-e!ZגK/ &P}rm[QˋXM{1FXUPJ <5@~gvZ\ (#ONu5 (`#/`|:W|7u1!"-Ķ:َ70`y6. #n)`c!S|{hKs<)x;y&n[GZP>7$(Y6:K^=+8Mfźχ POЯ[Am9IZ\F\)FæxKӟHm/Ð.wI924JQqH]r+]*;+(h#1+$G P 4xUs;Qnax8EH˻g1p)xL#-ˆKk(+?}OX_+<Kh7m (S+<Kh7m (S+<Kj;CYY#$H]z1dUK1{WQMch_\4>9_~_|+1f5ۉ~UU!AvQI$I'C>>~#Pϛo. paOPH>7^x@Hๅ}J!Ve-2K䏛;1c#'=L8UnIS}gSyn_g7CO~[ow0E< $T]6(e>GzKk(̞6CWߗ o%p4ao\6MzC?7m?0D.o&>C?7m?0D.o&>C?7mo:O 3 utՊsrP2 }>ּa;=?BezNG* ue54q 秞kDTzzEQ_0lQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEs~3뤮oc}tQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE_C3o sMuPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEMz604αsc2Ns:o|?2J(?ag>|?2J(?ag>|?2|IZx_A51 9iq'rko>8!(?ag(o>8!(?ag(o>8!* kzuo =*L]XS.b;,t[SdeFv,¨U9<Ux/ i5-ͤK4nUЕ$G_B(|qCC?&QɕZ|Z(ݮ-2\FVkΛL@U-ǯEo>8!(?ag(o>8!(?ag(o>8!*Gihoo==n6D*9g*xl/l7yäڥqF,mr'h溽CZAYcKEogYP:@a > G|qCC?&U/ Z.?xr@` $3 >>857ɔ}03etP7ɔ}03etP7ɕF뻭NuM,e}*aC"pFN3g†WG\o]蚅uR{ˆX;I9ڭ\wR3#R@xrI1|?2L~Y%2'T$=89]sa > G|qCC?&WIEsa > G|qCC?&WIY$׭8!(?ag(o>8!(?ag+񗋥vX3k:;AeaʌY߅Pry8 Z'us[ռ&(2FqvxEbO#ɕc'ź?ZMc4smsi9RMt%IЊ"_k0OPKifX̱ey85~|?2L|?2L|?2L/|Mz핗5tT (Ŝ-]>YT{Y{lU.$r9^?agʻ}OC\dKk1rz\1 Ks\ׂ|?2J(?ag>|?2J(?ag>|?2J3kn5 4 e -IcoarV6 :2v̍ [5Kc<]ZѱW] @}03ea > ]%03ea > ]%03ea > Z>$׭%qXU! hs×ڏN캅͔3][lTmnW HcҮ ğDֵ>Zw:7 ՜wHvWsmqݼW08xfA"0FAJ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ~*nK\@< Z먠5z"^xA;xtTbQE=Nх9ޕEQEQEUϋk-<7Yrx(>hw:=_u6O|VW/ney K}U9~^M46DWVV PGq@gn|]sPK[)KbE HAb@קP0@(((>c{iKzUKqg`4SP#q 9&[j?S,e%&l6ErH,;W^((^5snB;N8'ems-[#GX~Ac<dzQEQEQExύ4oGt5=a((( ko/R|/%T@Nlp31u@_)ܶ[k+H fXmGܱhdGeJb6Q5@X'$I8G=>] M?"21b wzMPEP\_ ){]uW's]uΣxWykM= Y^i<uUN@mߖlč~.56:۫g3F ɶ P9c&pUCSQ.4]:wE=1Ȩ>;dEQEW|G% =*W]{Ey)(YPU^Eye^6hڜs2XY2ma]$cq>hnvcsJ<͹ ml־xxm 8##Ν@Q@Q@xύ4oGt5=ad3u"(ĦQB@>Ν@Q@Q@x>}mm%?ABڤhI-f.(!q'Y{;iSζ/rg"XDqb(I9'M: ( (9wsERW"O%ֹQ~P[,$Sat]7Ѵm ZF5L%#tىG<23; lzˣKWxGXss )TgyVćOtoH}jV\<),8 } 31 7qŀCzmGo+̅ !vHT$a 9 y'^ú^c][GyϨ\$[rva//#`ִYsTUHH?y 8r3Hwhֱ\$][ځd$p@Ozo ]2_*'("3g'sG-5i:JGkjQmc3D-9 TGJo/2xÚh|ZZMۅKTXYu)bAw<`#62(-4&ֵ4jZضj-a%HBA6'FVEsۥXGi2W?es7kҭԫ aw hĀa< iͬV"$wWH;s<펝+MZjV> ֗I.u Gf&ռ& m'j}}K`$<RjXi[$M,1C`R0aRK[2I&:KZiyeyu"6t%d ˵rLR"r8M{g|-H$rcw^qFpr+~!xsC}uipJ%F%؎1s_AZZ~mEqej2%iK# ù?0csn&k'=H5s``ǟI&|By7wx͢%E7;m̬yfo|;X1Bŧ\u3$|)R˻hu,kֶ7|q eQ # Ѷ"2s|g{Y{:{o[3[M̬rV!$‘zMx~>K\-Ρe2.wTI][19$ֿƟ"MKR{-El$ TH&وr@=J_?K4[7U+UH@ZTQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEUi4bK;w?kFJe0c*9U(6#hc7FXe;Vqwuvw]Kond@YNzZEdE?A{5ZÉ&K(Ē0d $JQWl|yK<33w=y4Pw] Et,F 2bC[@41ѣIJ TQ ARQ@b45Ix8;z'F+8WzUm_E{.K1섮,S,MjTb $nVע92FO[M/ ZXK $K9`dwqfbN@ iZ\Giwrqn U+pVf :(6_hwvoCLmǕcjn>&iZen$X-dV0#8$g(;{h-Po p;V4 ;vY'$ǁM k(-Yy-V鱠Pb#( nEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEwvDd+L  C (AFigure2RuÁ\Tw? u#FuÁ\Tw? JFIF`` AppleMark    % #!,!#'(***.1-)1%)*(  (((((((((((((((((((((((((((((((((((((((((((((((((((  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzw!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzU" ?F((((((((((5BUSx.h;Y#49+C^KR7XZ ͬ%> w9?9pfk7e;+k+qhȒ( Ι #Xaa3tV'L|Ec³$$(_nI>͕:VZekI\jڜ?ji9ˍg40+n Q!fO7WAssWSG(dY\*Fd kGOxNHYȖLɩBDjln3 ̣'ހ=kzVnZFg[[;*H8z ( ( ( ( ( (&h~,j3j-ݗ-RF$ϙP }0MvpWT"oM\\'C?U;PU1_s2tW? leG'C?UTϹ}9sOCf(??w  #}a̻4?CQ leG1_se(١*OCf(>rs.AQq 4qMr&6kk)&M,-iHv[ȳCh72۫q ߂Bx.7HK1ߒH~H$< c1YW~)/]SWecj+~(x/Wmzm7yq4gWFl}PH ;PUb'Sד5sOCf(??w  ~rsOCf(??w  #}a̻4?CQ leG1_se(١*OCf(>rs.AEywjO>G~ݷcnٮ]/73IjyNyNAٿ66?'f»77ze7ut)৘U06objk:aOV[fGasr;W+Q@mσlK ]E&Kخ'#bma.%|av9 |*65{ڜwd>~W]Z|qנQ@m[_xkWQϊk]f]ODh._JRUJK,la +v?t; ,mUֹ0;I%$Ң\?S[]}o?%]Ч&@<B(x/*sx;=4?AE[}9Wc)-Ч& (#~Kaʻ7|g1b%{aǷs$`>~x[گut}6_HPuw=d{@7Oen>*b`c}rUsM|-A9]la[|7Cϣ My}i+nbŽ$S[]U1sI6ٺV9@<B?w z akx/v9@<B?w z ak??S[]}o?%]Ч&@<B(x/*y7_xkKmiҬ6Ooen0pʠGs<3`_}ꖲY^Zɍ\F#`28 -ᴂ+khcPGQUE@ ꫏\pӻjNWn4Tm+J(Š(((((((((((((((((((lt(SjP̾7b0 9vՎ-7߸I YYl}T8eEy޹^ hp>u iӷ0¡caqwDxHt;EX.5Oc%&2';:)]I]SEr~*G.7K{$YeQ=V2[c+"|ԕ۸7$5 ?$WNnoab\¢0j+`\l7b0 9vՎ-7߸I YYl}T>ށϪ/-#nu3bU(P*g*mÐ WW:E/."iMia )+u8++$JTZ\uKy.?YZU{t\6#vb#HQ\O5Yxj}ZMS{c"k)n`1nQS_-j-{4{[sC,Am\-.ˑ(_1\/rSogd}Y|OksO/m%Rrd$am2qӵyC+Mo\lcAzh(O xB&ZE1dX:їc۠((((((((ǬijSiQj6j0'-Φh׏;?zf^:{;Y4I<.c`0<,k1rI+J߉-yßF _#sd??_WsCH?z|9$n9tz>7?n^b7GNc@%A!Ey/O?1ßF< {HwGQ^ _#s/td??_WsCH񺥫|~-qsaɩƙ;i2@7Qܞp G'e%kj!|]:琷3DR܍sALT{nhdG,l]H`G"Ou_3kmĿ*;($I$ 7gMYy'fbyuJ(e!i`JR檵-q c+z|9$n>7?nK'1y#i +z|9$n>7?nKC=^b7G/O?1'1y @ßF _#s=;(?/tsCH?s/i +z|9$n>7?nKC;M3XuJm5m-*#8 U٣DMCkj3,,pxx\p4S ( ( ( ( ( ( ( ( ( ( ( ( ( ( (9cڽ摮ip[ItiRN(H_uS{ɭ,ۜHA mU؅M?!_;PY{Qcr EmV&d`@m<:^Z7s_&ڥClcVZ*"b!F$啺z(:qkv6ڤ=`fE$'>HdxºT]9eUN. ̵H',(h[|Dnڥ*wug ]eE8dvGev'$aAwQԣe-Zkc$Q7ؖё:! ) @K]FRk՛ThmqJbkEDBP(Ė|@.fk7^z[vcż0yS<}c*(x[VXuԭ Gsm%4m*# 0vx7J{u;=OL^Zo9R2ʀsbP7q]-2{=MIeKgd,ywu'":gkk}_76QCkbGndppNǭ3|9?+Fe g]rqg8sMW7x32:J( ( ( ( ( ( ( ( ( 64Wvh\狎]=&Q(((((MiwvW)Xd0`rP]㟊? jAwܹr&8ydc 1%Iea*q$>~7}k%i嬘k"6#*___qp+Kv7ΨEJ(:(((((?D?/'+0w BI.֚+5!CٌHd_c_iV~\1MaX]\B HĤdnf](Q\K=;KQA$w)-yX!oϘTxyOjf-NA ̺E֞\C -@Erz?oޱ6yck [HDnb//A@[KJg5MUcH,-bYq8I~ z+̵Ku/G XW AiG(f&pYXcvK}\k4nk.r< qE/mbvTW%PԵ y~ej8$yJ0Poz]YU3GltR*xbR]j`D4C ̟o4OOy]?ķVOq6y$)I8POy޽cZfSyMmigr#fcǵ{%OUI}h\gwϨ>@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@sv^9ok6(.Q̲/Dg wnW+Rִ3Zi#}-lKpA 1[,-%vn˫ݙ\=L>#-ˆKk?O:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:Wao\6M|F[ Ge ɇ:\\Ci73GId`KxI5Z_]*hˡɈu9I\ɓO܍'[; źoVѤ"5}c"(09$ U? ҩu1kNVջNjvE|k>>oMaczńs:\'.Br*䃷~JPQtxi,H^B+)( :&iE}v4eE 8|Q!fO7WI\ߊ?9 ((((((((((((((((+O kVEihrAϚ{mpV"⧇UٴЗQErQEQEQEQEQEQEQEr>F:~<֗{w=Ǫ Ѐ:|Ix}+[M?Mpn/egS@H[E{~N'e_|J3we='Iд}3L6E c̒rIxSFH6ZN41&pI '&iHwQ,Uu H8&Wc6GZx?J,lwh°_'I,='[j6px({Ӊr b{mzGzVP^C$DX! nx0O8үZW훾~7HbmRd =TO4P+m-E1=]gN5,R2D#pWw. 8+r` ֠_ h6Z}?Mj$iT31!J7a]h_Hߕs+!}VNo YrB4y ñ3 Y45ti4ՄqxqZlI2 3#Kl5X5N$_L[Y1)\FTsA庆kK+ؼi|f!d@k`qST ;m+Oo!𥗊V;YIY] ˣ@WSH`n;XE}2mf. pyeQ9oWM-eƟm iɏg7|0L%2Z'SOuoe}f%E]r9 *ċv3Okq\2]siKv+z(h%$d />Wv;oߓf/{+ngOwf|0he.Byb6S+]%VnG1䵸0$<YR${*גc @SǩCro)|#w' )<-l|C 58Fuı,y*èWi>w_esmcjF_[.JjO_s~Jj=?xRW|c_Aih:.\ Fj?C#Rz[T76,.Q&~s.>p3]4Xx5HQQ4cNO+X(|(((((((((((((((((((((((((((*A%V'=ԷB7 F/ S (U(T[Ery0]EtcB`8(ʖSz+G<a?y]%s~(?3'(((((((((((?ៀ]h7Ov>oc({aEo EHRvVmwY^EV1Sm+:4>o/̬<.::2}$A /pW\յPnYP;H ~RF^3R=vϺ!-Š(4?G^F^G|;c8=(*S:q~쟝M&QE`0(((((((((((((((((((('6:7vW7^v n9ϟ獽xҮKZ2 i~{+KgZHYO!\'i8xoAiB;k}7O[e did?e=QӮ5;gOyp]#ۜ.rx5,uahtKt{2K1d. #H7buֵU5K8{KXDbn$5\ vvV^#:St>ww<1m]͹H''sTl xbڻsNOҵ+^k#Sԭm-LT$g{|ej7-Wt9V Byf1?`V'*6:uqz>Iy:[{mb308PZA%;@:OH ^Үvkki0Pq,$x=Ǭ^#:St>ww<1m]͹H''s\G4;KR!ъpRѼ/R o#ne% sV|UMPK p3&mo4vX틖9P,,Xqj:e^T{ԢtF$`J #5ST8^Gdi4iD3C*VbB]xӵ{n!{-N 6wmqbR)AuPI]Ag rS{O.Z}Gs-"s{pKD7#s};k/4u֯$Q-M$X# }>Ye4+t'%hΛ-,ћ[+2>mA%0;{k/-⺵9A$RE#! \?9 ʋz2]|44M^EI(-/-e `Ttn=^U\/nNw2̜| V'<x#NMm%I*N]qmEPEPEPEPEPEPEPEPEPEPEPEPEPq^ RI29X8#=xHD/Q]9_C*8O<7SnܻQۦ.vW‹sBO\?E9w'p{<~y_c>ҾPq.VpQGR@?2Ua)|Oqs;`xA%cA͹%[ $ۺߋS?<)o#i&o,w4lU$dWsŭ滞+khdyGQfv'@O #rX)TIfk]۽rU7SxFXmY[TqنGH oϚ-&;9.pon~c2^>WNNSM}񿭕Ψ+OWEwZrOc$qXG>¬‹sBO\Zw=xImco/}ǖ$XOzʖ%ӓT\JuOZIEWQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@VO/.krBT`1\v)ld@I Y ( iWyIb@;[S2H6hsMW7x32:J( ( ( ( ( ( ( ( ( ( ( ( ( (1MM-cNPrt(Ԝ۲E}V[QP0/ 7O%E@Sc1s  GiEoKZg riMY۪Ubi=Š+?E״Zs< $S?A9(I-_QmMė~&f{{5I?է ǹ)¤u՝VL(Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s5Gi!vմFIW]r;b 렬{H۱<[7gȸm^pq(7Qä&K\}ڤL.S;|V , k^o|E:ޟg<!yj`d;w,q#?쯷gW!/;Uۦ"֬jϧ9q$hrJUI >$>ikYꗓͤjk-r$Y (2Uʀnw>IyYj at_]LyT(蠘euL`!F]"Tգӵ>MXhٔ~y,Kn 6Z^֣%<؀@cuެ[VBoP` ׺֫ ѣS%8730Umꁝ̈́{+?"wZoWa.\WuxCA}ԚXBh`$+iK2uPU:v< { 6WD}rdj2FA׻փo1&}%ͼϲ@+s3b + ]?־v_wm3dgֱ,?Ju[L,yK6ʑ T.˨x-ӧ3H΂'Ym9*̟`ԱC_t-RIxl0 KOdKk= ,Xe1>Vc!DO ju.%o9gWI<ݷdRvҵ]K]M0ܙ絒"Y0x pd>S)#rv𶫦dyIpnm^[Yo>VAY2#%j3)[uR6:%gWS6ͱ. >l&*f~}[2K,#P2YI5#<'$^,K}ZI&dԡ"567jnQ݀^sm弶P=c)P2H`kGAxN8'Ɨ̩,n+ʧڀ;m+[ҵv5;=J$Ȭ%IRFpAǸGJ4ݭt2Mw24Vv 3b3*QEQEQEQEQEQEQEQEQEQEQEQEQExW}E]i|I"wwLT qF}z'C?UyWZ]Ϋ麄IwiE qN=z OCl?M}Vy/*Ӟֱ>nE`6h2١*@<B?w z ak䦞4?CQ leG OCl?Mx;=4wP_K&8}A6_4˅v\ }dn[ $?#%ɉ(O [W4P]oS#~+~٫*$Q$#"4||mYc54OG2VdUu. Tf à -E5ű ,!԰(6ȑN_Cnihrl~bvIS.AfWs,tm.9.6 ȑo 27f Ƿj AmGq}xQ5w._afBX&e3<}`zVoڃ .hLW_huزܬ_mG*O7t߬Ee;~cCSXih昷ʳMm4A [r#<6[i^ u9 Z$n̷bH[$.ȕbC4~a#[_?/nlۏ>I's+'|3K:UhB],1K $2R]JmWwviz Wmk/ ;*݆,i!Eo3Muwq<0,mY"*،D{yEClu]7O--flSg1wdSP"Ƹ;7%Petn-m #<.{]"+Qt{k5Wn4ָ(\~ЅP3(6nnm_^2xSPV5̒Ğd ٽYG Co}ZsOOboe&<7~'6qUxsUִȮcUt\Ed+$q,v' 9uJ)lw.Z?=’O9$׼_]W/qé }r23O&:^\ߊ?9 MS]'?Y%ۣޛTހXc˞EQEQEQEQEQEQEQEQEQEQEQEQEQEWtYۿE^\?]>Tm]Il6NA'MG0ґxCw<'yNS[?@ :<o5=ms OmHYDA[Ӊq}_}Ĕ<H97gG-?fslԁt?&(?0 g[UY}QI|,[;]{0Ai*OZo>"iv^jKigg_6BFazZW8r;G7}w!h`(((((((((((((|Ymu}Knp)$dc@Um?Ro-%ϗqm*pH8 5f ( ( ( (V>oyg~ow뷞(چcY}^[E2U4e2HR( dړ{g/^u-5+P]t1eBH4zsMW7x32:J( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( +Լ{IOoh?mJv簭QPu2WjiQE`29-Xc2&eJSf%6Kss4pA $F d'OWdWi>)t.&"%s&NZE?r6Wl;=q N88+DQEW AEPEq { Aտ78Dmڿ1ڻ *5Ui+Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@q73C>:6~nݰɻ<8\UhX$wn?2F2 gY9'w=9^mv:ze#vڅ<+ ̄' UZ~=坮, fĽtoA#p k$d`Ԟ,$I#F1䌍u9?FqG?|ۼϳols@kkD4$ʹ-u1hvEvE3J^T[jIQm?|9.5;[\m1G,91 ު 'bno^중/#ME:$;rʠN-axSXeh^hauDyp |,J7#Ŵ+3h7FuF$27+a??o.7h?g/w}V>j#_~_og14m? H;o֦߳(.]̑ϙ8*6Uk_پ7_?0wZ$ߤb2blmhȸ}mng[gxK뷖p=%vd;T陊.ב|e[G(A^[g{? |3͵辚+hIqss!]ǒJzs~:6eC^6!GheQqQ[vEƫ=Ɨe\x\{ǕG7i6Zc*A1s&Up#ַ_m{#_:lqwD_-9fIehyKq3O";w*9b3]Z[{Ԑq$rC3,M7$t8,V`x$KC'u,^]2Z ȑQ%@`,ĘEK5q@ Xmmeʩ.w"۔(v_`.6yhGgWon&}*kFڔLe2+HX!tEqۂB ϳhy/_n|ݧf݌g._ ;Mo;otvٯdogd}Y%_]/|ݻ((((((((((((((((( ?O! Gݳ/H9Rjԯ,~2{EӴ&v2n~zSTc.X$ӼF?R?NQ@s \l_#x|CⱴR 8,䓰H?!k>ҼcMy㣡'؂AgبUB.+y5YD&|+_B *HџJ*\nurȄc$q\ ~WV!~aT[jwFiV8P8K*S GWK}JIpxG?ԏWhӘ?NO6y^/r_#zhӘ?C͞=4ȉ^O { p< xWZV=|*֎̡LqPΫSVI-M5QEQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s~(?3'+ogd}tQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQExU8 ՞FkWҖuWCX(;סkϵ?պzDӯ \HP( ǡ ߰L>8!+9L>8!+9L2}icA#DK\Hr?՞8xoTjB˶sΥfoG <=xs@a > G|qCC?&U/|E ?NmtlcrGڄP!p403ea > ]%03eQS]SCK;_Aʘbȹ簡|U-mv&}&a2ᇖRc`}nxœxe,-4yWSTHʌZGT*yP03ea > Oga=Kcugw-휬pYx=A9L>8!+n"v (;I`}03eQ?>mdTn!Ie94ê9=MOMĚ4hukW.')+UNQ9ַ8!(?ag+'Z?M}4mmiP#D>mCP4;[Y&-}*.z5{>8!)<|OL6N^K2K"tᔫ :*!YxCUw{j*+S#nL>8!+9L>8!+k^.AcͬڜS$^c*3g~B)jiֱohwVn2$e<|qCC?&Ux/ i5-ͤK4nUЕ$G_B+Ѿ+  G|qCC?&WIEsa > G|qCC?&WI\&Rw:M^ObA .BvqhܿGihoo==n6D*9g/}03e_ռGĄAm2Y1r1 Z.-5xyUT9b@Ӆc 4'|qCC?&QɕQ@|qCC?&QɕWj˫uƉG_+8!*ϊMwHӣnbmb_{Q6{V?4RSVsyH]-ée)UT IL>8!+9L>8!+~+;ig`B#dWxTjE vJ6 U[[ RmMVkTGn.(Vφ|AiO,VEJ .z#8 L>8!+9L>8!+GĚC[m`icE dzJG?qR[y#K*d=r#qG}h~uhvV- ve cl݃' t*|qCC?&V7>'6j:}k}un"Ac8!]F8+x`p̂DaєP?ɔ}03etP7ɕGWNk}SCvqY&HN.\)uq?>'_f3jKʚtOey@>Zn8F ?ag>|?2J(?ag>|?2J(?agʣ ֙ ZrM Ҧqe vx-8Ac{8Ҽ {~[[YG̷&5@F 60Z^ gѲ߿6q Po|qCC?&Qɕ|OҼKy|3FnZMRc+q~pq#v03ea > ]%03eI5u?[$FgiHd TGy#Y>+xk]tc:}[XOf&?+H >eC? i4kmkPM#EIhn|I}m[|?O j* YI'x8odwnk}|7z}F-RM-tƘ)kE?:pSq] lqG"81bc$&9Z l}wJXn$zɺ19 ydWcEVo4FSZWzZTP/LxsS:\ַ*,w1D1޻UpWĞ*y~! 8#1j0UYd!*Ez6(5(8aQ@s5/- jAluP>NN8*A#A(#⦋{Eg5·ZjXU@'k1<]>nt'ĝKúݼNu7L1,{[^]OהGڴ.NJ-.,(d" \$ $k9dv9 uQEom5 xJ@n,^fx T$n!x<נ@en|ͨj6+L8GLciDq \Ɵ{9 m.;y!"RXl]PxE'm>`[yHGgadRF8 EEFV{hz߇;-Z̬O}ytqNEz1)FaP2@ϧ'PEP^_[k{YJ0 FOl(oF;EҵsVq$и{! /qSko NWl66dW(5V 8O@Q@$ҿ|;ihYMku]W?y_oX 5=<kq=q; DCY;}}Ƈ vt`moD^Ud. sLwgm[BuE$*A$rkШ((s/}ojnoG=1xXmP9%^S/Q[*8LI $ĐQISLQ)LW#~B<-"_C*$@}w 9B(ߊE9>[WMorp>X8^-yxGαjPXcK6xLY d& p0F;qMXGwHZC`0X>? bS3#%.u vg~w >Ԓk袀 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (86WxV2ڂ-5e$+ϔ̡\J3ְ$kJgѮuCZEmy6V|FWK^iW5ןe޵ݙso4;s?n?w#Z8.|3@ye̒,F |\{ MnN>JtI^FHRmu_0b'˩xӴ{COaլ]Z/>khWPKm'EQ!sZ_\躴zjjN_{!bFZ*"|v}oR~ߠje SrBo:6733zKa0EOH\6KV11;X! +Uu ]\Z=FPY!ʌц* *b2kx\ɪ|+<. 6(+i€s}Hı۫6ϸmfp3~ A_Z[4XkPrKh݃SHe9;-BIY_`]s5X$fc&Q+oڭ7-|ka{ɖY^Yo#IҼKj4jV . xH*@JPAmῳjnu srw;O$24 UB(UPGej+oLPt9Ex1Ix2MDD΃k>-<'Ve%Y! -pI[i420u \Yѵ}>VPZ ?fVVY| :bmu_OeMe|O&XPF67Jtm׊ZMd.vًu! ZY0=A"oR : i]BĖD^qiGO5穲r\,p¢wÚo.kwz5.#M0wq ( Çdx-FvZma;-Zu՚M2g ʇ08ȏ GZ48=@7n課1DF_4(xscmIbO'hE@ *( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (?Dd#7L  C (AFigure3RuAHߩR;Q FIAHߩR;JFIF`` AppleMark    % #!,!#'(***.1-)1%)*(  (((((((((((((((((((((((((((((((((((((((((((((((((((  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzw!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzU" ?F((((((((((((((((((((((ˠQingٟmY4[xVHWjo6pYªHvzxOu^[K",X])O R$ZFu~Vއ2}V$=Mz# $j}O_c?Thuu#&ߑx}lQEK@="UN-eI;+em䏨\Oğ3¿_ oݳgnm_lݿ\lh>&\0,:f3>Q9 uZOeĻ%nI7$nrp8RYL7hr,LA#l2ƮX~u8ӴI-fQ+-썇1weo1ȬWj1A+Wot;]+Z}KP{Z Kn 崱Llv w5.ck |j9Vۆl07ō_xrv<>5ZiY]RW6%KDHȊ W;cͼ6cuhjQ}I!\ ;c;;;}V,s J/$+0aV[J,Il fR$d%r:= +9w6KI7lo^'_j6zw>ьjeŮɐe͐Rm<==WWlm<\aIāJKf\$&UeRzܱylxrvXobRĶѲIrMk~++:W7Cr7eg mm 9GZgе̖L2Ԗ@b dc{zZ~>$Hͼĺ_yg7s@:g_Uŵu}tK_ˌw-+`#ݸ"}3xj# peU$3)LJ۶F:%IgIZ;:X,|h7)wVE?PG9K|"\w;V >tE(% 9Ho$~#<_?C_n`Gh{wKw*;Ue'rbb?F'&z{ſ$doھNݻ_9PEPEPEPEPEPEP_9_ ks R029מ1^Aߛ-Օ]z(֬xDO"Dyw MΓ/hg38^ F[:|rOuIs'&o#h??7/?EK-o*>CaTes>3(??7/?EK-o*P}?Xs>3(??7/?EK-o*P}?Xs>2O?l>iGw\6d𣧛&9x`c _ >:ܥh3a N\/rRL`<cg|Tlj<9⻩&*5(aEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEdk>'tk[϶=I$QYOtP; 1d |oasyYڼI,sfepѮF#XtUSYӴT}F;auu2#DP9$IZ6K9q4X .b$+m*I `H]Z )bp"Gr(!xQl1S`g9 -BHӮ+|K8^y[b"c 8h[R-t:RɴM")f8fE[R-t:RɴM")f8f,EQUP_4,sC2A*@VfʠDbONEPE?t]:Pa $lCV`ׄ~ *PZq .(G @'%QEQETw lHAtLG90Q‚q2zH (چkYyy/ x,IUTYUU I"Ѵ4-.Ky<B 1 \(',BŎIUu [`|3.iƒFG84QTo5:OӮSwKH Q I$2rZ4m.KKCMm"{.8R ]Ҡgy ӝ @O1ǼB<v W'?D=mZ^]YG/M4LXV20 22ʰxן!(((((((?_4OI󼏷KmBg8Ȭ[ xm+߾Fn^Q[EEEп5jlVWQEŠ(( [J6A+/ b H>m=ur Rc$`tS,pWhFg熥6=v[nC[AEWXQ\{}'7f|/]w2:{V0)ӅI/vwk$v (W? k[_ly6Hr3޺ +Z5gFjvZkjՙiz-"v6 ]qdօTNnrrQQ\64Ј#֮PK2xQ͓,.-5G&b{,04R#/8tnAM7}y%ĹNSfY|ǑqUW~׮W4JFYG3HPYII84[sxv;庺a%.lq*\mf渝O|?x!Qr$_5e'~f>Ulb+}% o(<̼cGC@%ݗmt-is$Н ;/ \N0`*{ˢkzƠ5=^IdtXdbg%B00ٶ>>oyh|~Wgwn뷎Uk/hzvq}sϻiw6e7M42 }PkDla;_'moqsy{,՞+F,aaJV*@],1cyB XԀ]SDN,1d1VROCdvb;궾!9nc P-ݲYPĨy٦$J=Tċ^i%֊ a"| ;YK`U %4=GQm>P]j4[[rr2bH}S6yv!kqqqjH"`A;Hwz-n}??.6O$vrO!M(c,rjaյ_zơ`5oq%6 ;yaOF&U`G GI}S6yv!kqqqjH"`A;Hwz{Qm;O-sڣܻ\0x'4خQ"p7L'(RVLare2_$`jgy?~\~|oho˩66ڡ22n|dh#'GAG#6?eO}ݟ1zqҀ8H (/e{!;v͹Ff.F/IVi%Ū}wsך CȮ{PA@=δ1[ Xjυk٦G7r'l$yDy/ʻMyn[l1uj@9)&FzmYKvWRč}ڹ^hJ$le,+%+q|(A@|QhmҼQLanG3.|S eZYjYjbV \]HnyQ%TtÈch/-嵺9CJE#X Tl9uƙci}> THeܻ[rʀG b8];]ִ[=0HfռAq{ g\L,"p)o2[隶jIS%=n$nT[ C$s^:LѴ]>wi$2]e@#1E4=;N,tm>OAj kn@0P P-̚^5rkv.'PߤfHfg1JDN#ɉ7IߨiMG6}w{hzeѴ;C2{{T3*+& ! G4?m?[ʟh?cwzp-Q Io^5Cvsuf\ ^>wY>lG}wR8g"l|yK<33w=y>$"C\ZC{g< g)!+[3%XL +ӥwIaGs$, Rz#ިsCu}NF mEE.#+$ fiѯ|y\^le۞cy"񍾋6l:6 {Q>c$n2g-x~K{)Lr\Ze 0KHX1)|Gy^臠 xzok:nAqaI_ݨe^:g=((((((((((((olw7wy^go~v8u?xGʓԼU_j3G|nnVw`ξd-H'R:+*N*WWkE6y^/r_#zNa+͞/H9^Eg'(R?NWQG997vw&8| A`MgYHeR9E= 0U%Vg1U: ^_RxG?ԏWhӘ?M<xG?ԏQNaO6y^/r_#zhӘ?C͞[W?,}E>mW\oٻ31^\< xWľ1o v\,ő|ɛ $^5KNx,M9F1rQd(5 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ((ΝۭΥw,{Vf=UU$^?dx|;kNd,%wh[["X+jZ]֣Kn}XEsYg _$첸ۅQ5ĖI4W$ba񴟔 nm_RҡS$~eщ)ZKn#bI-mgP:jQOe&}P%q*n qs .&gHHAg`=0w$%y& XjEY!3߈V@* *"{1 Ḿ,o乒IᴸYtK-g - BJ_* Y3 b@[˾[ cIsH##uV'}W6C6|؏*,Má$qFE# sF/xŖs h. 3-qĘm+HTHpKK& K{Ee<[dȆ81˅!\֥onoOg>m|_?2'jvJjQh_WJ}>kI[yD֮4Ab MѬl$S/*`IP_MhJ22>e8`de]s`1>#<_?CwzW}Fsy{͗nzyn90k~'axGOIFV?eܒ ϵ@n:+Em ]IfD i<,>m'WPEPEPEPEPEPEP\߉sWVt.]5@Ur.\ ȽkK>gyn}wy7nqsשiSfE*I7G^/H9SO&zxG?ԏg_ɞEy^/r_#gQ^/H9G>9W'(R?NQO&zxG?ԏg_ɞEy^/rc|aׇ7D}2;&Re ! BO m)er5N5aw f 6=X<dptvcvNcGͷenQfA ~ynnfys$ř؜$I9W'(R?NQO&zc~.B)嵴ٽ-YT @ÿJԏ|W "ٟMw{ns5ՃWN$Rre;Ee8u&UY xcY 0Fpy5rȉZ蕮D:ӄvMj(FQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEUcXlPDG?B;3*K2=j+R1[.DBKYHF5 C6I±EPq[A$P8fDUC1NQ@Q&cGgno}ĢF6[9D?1fmK,ֶvUw$wcԚJ uehWՙٕ>`ZY ި.蘎6s`$d$496Ǧ\8k$A# f@IW?zTv>iad:uDQpq jQCpFO+1ŭ7sɞ'26IV`s&c,Wgn_gh)[C |EU<: 5 BJ_* Y3 b@[˾[ cIsH##uPͽ懨6j|Qkn]FW I<ҬMSV6j]);Ge]lGgU,a4%ķ"-ŬVP Y9$ň!cr'+5zۃP_MhJ22>e8`de]s`1>#<_?CIEPEs~Λ[^Ҭ`} -:(WmιB3uF TVz~*bM=PQEŠ((((?RW|iY݃: FH+pؚZ=ޚ (QEQEQEQEQEQE|?,jj~4HlB3_5@Y9`o F~<ۉpw{ϢzI..![P$0UE%<$~6/k sC8wo*1'yS9[{\F+MB(((((- Op̨6ʎrTOnQ[P:cZŦS21MkGҮZ7 i2JHIq@J(IwցETQEQEQEQEQEs~9Λ &WUx&[e[DV`Y!F0kFJ*J{!6:J(QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE@vҿoG}*>it*!>e}r9EF'Mmmg%go}i.<{H`A@:W95֑izmáe$q(O_޾{h}((Yygѯ+ySqǮZ[N1hm}TB`hAs&AY: ,a}coO>~^8TtoZ\[;;N;,M嫜e(jQx[R FG>,PnǑ.&@+JVUE];]ִ[=0HfռAq{ g\L,"p)o=lZ{gnm.<:ľ\a&MˌŘz9U9uƙci}> THeܻ[rʀG b9t=3V4mI>dgĒM3JpQVt :Ď~zɥXG&jz9R{ -FdvfsdMT3caive6fU*VMB*=q?&~ 7?oڿd}O;3;jJ>!:-KF^`ݵsnbAـ.ˑD 9lmciTGק*m>w<)vgc|4⿟Uͬ6#ʾ;Spvn3ёH\Ѿ'qqe FLegq&znr.xx+y iqku D$gãcRU\I2YۼWZ4JV(6QUy8KNߨݿ"8t|_P~dO=B\ Ι/ʹzHp۷ em"-1yqk,"rI-#b0XܦI y0ߋ: >8L.mŹQ^E>; uvaݜN}0D.o&3xPkj"{)<5<8RJ`Hqw|a=!^zY.c]y&m o%p5W ,/ o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC o%p4ao\6Mz}vC-|jRx7hxrf\ Iʱ@VApTk{'i G,lU`G "t1\EE۹=Tn^ЀGk.a; *`ב0a&T:$Y `Xg Hs`%>Ey.jnYiϛHſxFۓY#I_ `H8PWS o%p5i:MevVɲ(c(dII5r?)RE.i|Qy&m o%p5W?h4>|?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆKk(?}OX?L>#-ˆ6xT?WQGKXw?( # O޾7Mk+/]Gr9rV^:^OGIʌ ^zy6EHWGQEEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEyׇ/M?M%QCA!n#hRY{㛓qeeInMԞf2fKo,Bq fÐDwz%qGjZb}p}P@ݕ񆇡x{RP CúdOi$[~Θds ps s@m:p(:EbHJ+:=[WHKHKVNHdD?ɷio;FocUnk{+Suuw<Ѫ̓DBZ*lcxSյx-􋤵k{i䉖@!L\vGwk=Vo Wd*\q&]*dG@m)-O1ovW U 0uZ6%k~RwgZ1 V0CHQURI# +/}Q{?*gO][fhpls^At^*5x"5[ٕ[Hc3HBи.^Y2Fb Gy^臣A>>X2k6H$%cD1_x~ziwTȇ[W qIFw: 2>߆Ecsnpl mAH<5&4\QF 9P1o#0|+O|)׻h?RM g'W?&RMOs +lԁt?&'9z@ :?lԁte?_=[? x@ :?xEy-مJiFn} Ey+5 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (fF#oUbXn`k-Vhh)rG9wY=NcI@~.үu }:My>ݤj_Ee4sExdW%pIe–71j+jw_˺ HV'#) ;k^ xf{yI8dHe#9TW7*RSP9| E"Md#dVUe1=ZћdxX+Q=CTlG:ƙcZ> y[rG(ť^xmjO60vIrG14xן!렶+YdE,N$R2HAGy^臠(((((((Əj^4usc]g.eu|sQc}+n.![P$0UE%<$P-c༵;'dF ᔐpAQ],DV"1ܙ%%bQ\%Q@Q@Q@|@ޡ⻯ [j1ldatg@2:d*zJ֭ZU"jIQEŠ((H%8 K#TP2XrIu =R;> Y3{yDlI\涀X[J6A+/ b H;SRtfM ό|OĞ\MB[#O(y8R~^|.ys޵r]ŽTy 8*yE}eĘ+vv4jaye}j63L̹HNZ9oݻ/͞@&.Ý~X5{w%Dm$mӅU 1' 6ZCHůwb~e%d) 3 8\1^  7&;PTd ̪b UIU PmYuR{Yn;šcKyBY`I}5ٻyh;]eqe6bMHFA`' dnK {<[d.8ث%F@%XGZk-']u2sYnzn ߊ~#Lt]BF-'D]:'- Hm[BD{ }iZu]j4[bv]FW I<ֶ."f=#((Ybp@lI ;|'q "-6xR 2 ( ( ( ( ( (9ȉo]薯.Q_~ٯ6/wL9T {רDO"Dsh_aF9Dh/i,M;/O?1ßFנQ^˿dYvu<ßF _#s(e2?->y/O?1ßFנQG˿dXZ}^b7\JMKr0/Mc}|m:2G!NFB1+5uNIw~JnTU9tgZOʹA<.$Xث#AE}+Eф>1o3]0H+j+ )vYe(-;K x2v@ I'츳*1^<7\&{?G=;lcsCH?z|9$nzǴ˿dYi_wz|9$n>7?n=]>#'sCH?z|9$nz{L}OG}O&_j4={ͺӮ ?.hTd$O/IfoQ-t?-\%DՕ dq^;K˴bBױQE|QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEsxן!Ś{=cO/u̶mbȎۜc< ǚ֮EZqAb.M|R6p9(V񎧣-ŝŻmek]HaJ&7"Jcd ܲ:klW۴ZucwsEOJ|Epu=^ n,-Pk+]2CT 1S 8e@NimLP62[H' !\,L^m揦}O:I5՟|k|VH|7pXٱ#-5{\{i&]Ycz*\wLlr7PQ\O|GCY?#Y|߱]$^B =pj(lcoXKn}#)cFJ+ֵ5_.k~mوI#M۷KEOHY,~qxL,7:'i%HPn c!≁y(?ft-2KwMgT9X"]BR^R8F$WJi2Vio 'lȟfe؇=ܑ@Ey߈+ #PFB}Zg<xͱ?PGEf ?ٶ?s߳jyK+gonqzsxן!|[ &-mMSrӤ@)6B1ĝd|Ng-|!"_IYI{YmzwEbi5y]\vI#pĜO۠((((((((((( vW7ZAߴNF{gQM`QE ( ( (}mΡy'kiIY-َIw7O{y\^ _#s/u9 C=^b7G/O?1'1y @ßF _#s=;(?/tsCH?s/i +z|9$n>7?nKC=^b7G/O?1'1y @G^Ҵ =B [Jcr ό~=2:վ?xMdLiљ[O`8/U6OK rI$I>Ql ӊdw%JюڟuQ^ZiҼmy$r >cyLdAmnßFיȳ=iR2-.5`z>7?n^b7\9C=^b7G/O?1'1y @ßF _#s=;(?/tsCH?s/i +z|9$n>7?nKC=^b7\2EmCBezt׎qgo5EraWTKRNXByMģ(v*,LZޙmR{F,Gx6ò ( Xh3Qܿhf%aJ`*`O.2kU 5kwn?{m:,p? p7P$^ X^SS]˹%I^AJ,x#![tQ@!Vj߷dy3>Z? V5߶'?g?~/]yIEs{5rS|[O[@$'˯xW45ndYFӆHco+#h7I y, y,wG"dpʠGКۢ(((((((((((((((+Ǿ2G[W] _ -줭{oɔy((("9WR2r)ӳ)QE:W "Z^"p7/B@#;[Lj[R,*\\8F,8r>wZMͬr]k14EУ<=@#2N"S惽gz|jRSש>CYR9A2p2lQOBp=xoUwy?yF**((((((+ǼI'/Iװ]<_e7~h;V˱25(((((((((((((((((((((7 úz'~R3B֌367ST|W/iz?mGRӛV <*B)Ra犼# 7_;Fҿo|}|wQOxGo?;vߏ??wdk?bҵޟU5-|AC#@ZS/M ȳk}G]úw)>g,څّ#2$`.}:qk˥HHI+c\B< }R6oe_It}cPai@\ m''s/Gil̲)m_5W29;kw&i\Ib(ι$IOoj1kKwci\[?YT!ʛvKhܟhT1\_n$C!zp,O+˽68}>/r]k1@1( *س˙6IluAm$ʼqRO R0At 2yʀrF% ĒHoVkIVK۲Y>/-U͗F㼖 JOT,M#(+g uY P}YbRQchIʅZB8/Uo~߲Y\;>6F1wucQcI-v;-xr, pLk'⟈=;#/>PѮI&tN e1ZIi}}|;Kв"I.U0BL7e ߊ~SѴBF.G-;.#+$ k[xחZCgZ,18 6I$]suWVฅđK lC) AWA@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@x =/wzCE" Ikkżeꟴ' H/-d|DeXp@?Q^G^ەUz?w  6h2Ч&@<B{A leG'C?Ux;=4? COCf(??w  )-Ч&NJ4?CQ leG OCl?Mx;=4wP١*;?xc?/;>{#Y-}Ч&roΌOdz'c }' )9sߛZcΧ(| 7gMYy'fbyuJ(e!6h2|W4 _~x2"|ܬ|"'kV "'kV ?3X삊(aQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@V:߈-/i; h,|+b@7۳ē,jh+<+[wKm#I+X/̀H,qQ\<3[[ZiZ$0[EX\%3 ܥ2 [ƋC`Ih59%l2y20@^ӐwAEq>-/PҤYghׄ|H6Fi(Mii~5'WZj o3JU$itHAG{!\n>.$VtBsYѯ%ʼh ,bƫ|Gy^臠(((((((+ʾ,kOV:ݤ('dYͷ\f>ֻ0XYc+1vm7&Be.Ush(((((ڵjzvVɾY<(d5Q%+_|g׼MKmCIJ&4Q#̓f B^rŽwziGkV ݘ<0ǞJ:89ʳ}?q,q5=}|cZ2U94}6mJV]:MFhp3pZE|e(lQEHQ@Q@W|X5-7ƟuH/5CPNȳn6 00}Ov`WTboM\w-1c)2# IEr&Ӻ(𷅴h<U_33r9{EU*Nޭ%mQE ( ( }ꖲY^Zɍ\F#`28 SMnvA1(#(*IE6ۻ)QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEV1bt;w/.]bh]k&Z 0pǥ mWDM4g^[Ew3G#^\Gq,ʒ $d*~W_8 OUu :PWkpd8$[VnMWU㺞C Z=f#IEirYCL̾Eq:g5o,4ӼA{,WNMࡈe71`@c c\O iɧǧcow5Y-tF%ee.pyQ@K-2Kne_m㟞E<{Rk> 8K+4T? {a i h7Fmއ05Vi \Mq3\$YAQ4tEqָ Q."Fiz]sO7]^1okںwKfR1!|u7G7M2t]G "[8/nH'䮶P񏉵Qkbkʲ6I_ɋ4.s<s[bѮ?,oI$۳PzMsxן!MO_}㋯L}Y X>e85Q@Q@Q@Q@Q@Q@Q@x[mSşt[E=w#In20FAxSQѦ֟:NȌG8fopyS4Vʜywk曳NNZƙi{l%AʟA  ^65e$%Z W3|yu\`dx<8oܖaK9.Yoo [[CB8B( 8WUpq=u9ㇴ8?Q]9G(?.@;[1r3ò<_ßzQ / =s+([1r0p?‹sBO\ ("=;#E9w'л?r?/gQ]9^}s~;u/jI7 }1z5SEjv_hf]<ʶp],J" I5ihݷi*qkDlQEQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@e-z6ZPWI]7-'XaA?ZKiZm.CEKsu= Xԫ>]HxOൕ$2FJG.=4;gpj"NPkLe18|`^5 Ϸiz{k _HbkG#GUnq2W bǖkk+T{ ʛXevGKU̓Sy5՝VP;'kip%E1ٖovEs\&Yh[+#ȽciJwG.#Cٗ?wWֳEpZCk.|3I 1$ ${rTnRX FoZX˩Zqh['9s7 y%C5/"}jYGNMXwKghvAdp(r66̼ ta<7P :H$HI3"q*T-4h֎F e{xT^{kH&s4<7zK^jWۏ6-Fa[;nJW܋n#,vMmo|/n$";{e?%EY e*d9,oj]jlI#=DJ1qUHYc?TO]ZŧXK^׫g A,#p)veXoٸEi7G2,M3oX\I B F{1QFd<$[w;H1?E&{[%IrmhHQ|KY[ $ı®fTRE\K~ .R7*E5I8 C`Yx6-[\׬=VPlR x ub4HJz]ķ]k9vk$E*@ 6YaIKmⅣaq;3!y'-Xr0rMdx 7R k"|!]4;6w5/^$:n}lTy>la[\ƹt',SOO>>{k=6؄L%e%m5 _q/mdז( 9А|~ɗ$|Gy^臨~# "3gi2A4BKOs,N"\۫[83|=kZ5i>đ{ӻvv#*IMO_}㋯L}Y X>e85QEQEQEQEQEQEQEQEQEQEQEQEQEQEQE/zg'ui\O CmuNAc(uIյk\yl7mpZ?-^]4Giw~Tg_6g<$׿W9j/E^ n#&ڞq7O9aG*os¸+*z ?S}_?Vc(?MSsQ ?Ey*osT??W +S¦?9(/.ǠQ^ 7O9aG%ayv;M[VдۍOS74̒p@&Q}{$42o3On݂<:b NT+,[~(F5hitRpKps|_¹VP!ITگz>h->]FQvղwf :y璄㎪Nr|g^⋥&O*wR"n2C6+ ˱W¦?9(MSsQ|X^]@7O9aG*osJz ?S}_?Vc(?MSsQ ?xZ5 vQ/I$xAL՛פW~"jD^[gK2 i$hMQEQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@sxן!뤮o?D=tQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQES4u&Ji y-h ԩ Fpx5Ožvii-pw;9PV=V콍{_bŠ(QEQEQEQEQE^'x ~G's&eom'KMFnxyg|Z(hᴂ+khcPGQUE@ +AER(((((7i3iZTs5\]*@*1kֵj:]bI%dQEd0(((((((((((((((((((((((((xĶ=MqEy*$+G75+=HLj5KḎʬHk>8!(?ag޽iOCkdY1sN  ڴ?ag>|?2J(?agʣ}Z5޻][bAʬ$o'gV.}:2t &mgVh,""Q;NO=Gg'ź?ZMc4smsi9RMt%IЊɔ}03ef|Oҿ;|aKn|Ek$1hWp'P7ɔ}03etP7ɕF_Om447yh7"dhc?xˉG<]6O ꗶV^amRWxpV9vcs].k ^$|6jq G|qCC?&U x[.|?zjZ譥q5r'B?ag>|?2J(?agʣ'k7z{j[kvtяehO'`q_r|=wqiH.$(ydeE cYMfBH. Vj 3 'Q<P?ag>|?2_DOL{g$2tޅeO=9"|?2Lk$PH{('ɕGHQkSCuE&qXxNn{05<#6OjVWѡխ^HxIU9FÃs]We^뗪%ޙŽ{x ?ag>|?29A+Y>e ד m38*|?2L8!+oMN7r=$, dpq@|qCC?&QɕW5/K fumNv)/1س Tq@OX4;kxLQ7UdϲGQ{>8!*DŽ ]%03ea > ]%r>.ցYG!TR顚Tn1ld6.T9o}03eX|J5E="ҾDEU%yo|B^9x'l>}1\m2 8>8!(?ag(o>8!(?ag+ϵ?պzDӯ \HP( ǡ }&wLgA+;JKPFɕgž&ºH{gi㵵瑶n<.IxS/Q4tm_KatF]Y`T@?ag>|?2J(?ag>|?2J3kn5 4 e |?2J(?ag>|?2JExf6qHi'8rpp@''ڦZaqukKofP69RprN}03e/<\;𕇈-<¡%x]qZ?ag>|?2J(?agʣ}چkhwMZ U,#\]#kյm?BԵKȬ23mUsHw$ b垫y1z$بw NH^oL>8!+7 kN gQo+k,iG̨pXx5P7ɔ}03etP7ɕ:~GyyV7wO xA+Ā /qxI̷)dnLk ŒlaG&ztM O r݌8Jעd5.Qދn:-1I*1gKMS-_I9G6*H;NX dU*τ~hz-ꔺH%Gir88.GQEQEy{M^0үu'[;W e^5O2/EPմmN9Wg,q,e6a.A`1ڽ6G!BrpFG?yO[T{ဘi \`08S^EQE>45_ j ),6.VxS^I:.]>I{kbܘ+/&L$N}Dk _1$ r:߅ޭj7|Ig q%楦{8F[@K|qEQEoa<>( jX`y ywodIQ@Y:Wִ}?Y\@iuˌ1-UT`|HXhP.s4n@|`۹A-=Hh9^7YXd0=A8`PEӬ~yokScl3H'Q@y{M^0үu'[;W e^54Px&[j?S,e%&l6ErH,;W?j.oz~,7:nJģے =k9 \ېӂ2= QEW=G?,iiz+2ç"?FIi܁J -.kzͶwRw E*FcJ&{fbYLjd@B8(+ moRx|Q"T6@r+)FHEyīXjӴ]Ft˻58|6r%`xy=0kgo4\&+hHr c'׀N(@𾶶  !mR]^EAk4 $ 3PT PxP5_ GH>FlDc c}38χmqi.\jf͖%rNڊXoQ5@X'$IPEPLxcI9ek`CGiP ogqcw<{97` @(d:l42k# }-uρt/ΩD+ {RfhI0{Wd9dv9 E9>[WMorp>X8B(<b v{`X#Xu8 >}jsu1аx-U9FC+*Abi6e1 r |Pxĺn5/K6Z-\iodbڠ}((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((Ku͏n-~өMEXg W[Ycyw[nϑqqϯ_kz$'o}:쥑NKƻ0лņưi^𞈺\',.[ T?621f |1kkf[B~G!WyސZ129vn N5kx5 =2Lɦ(>Zʅ39>1# *ZOGy ZG!hSnK('da{# ( #j68ul죳k[I o!63|N˧^iZFƩ]3$^<6Fݵ][7.N!5$O)@oFw);RXKl&J\[DG>"0`L%It6u!BbXkY$R[(pdVXA;2b/H;n7RnǕxaۜvx99϶w,9ewpl=̛pȔ.y{yb+Gd9}ܥ]7Ɛk7]N41JR ;wJlo:VO^R=n&5+q%xC 뱂vnF<5<Wz7V:d4DH3>b]O]ibIKK;d2"I!\bcnUt.|7@l[O~{'km4jCȓ%-}gxKCPTRYY]VI˳d9c+@D]4#/n /Y6Hnn@9&˯jgsZj$oDZf8W*Kv61k?Ŧ\j?A̍3I(8!ve|ԣ:vu qElV$XYK`\+GNFAn{|Mǩݬmog |]o-˗kO&%"=}f"a~|E"ͥ='i ?*Mͳ.qnV/5?Guo]KFԼG[kVipii4IISwDcyF b;u߷CkGg$pUȕ YfBlF6)Y Oߪڑd@x+Yu[7Zw}*Z HY/?tW?5xBQ^$5^Th7\aU!* n%<=c__ V1"*2>[$@5|M%mӇȍq'i/Eg ;Vկ>YFӧYNA)c,Jdb88K oTo{'N+KiU6#,nc>ÚzKɤivM%knm|3l;EGaItxt-GSKM;O F<ᔂ@ݑ@"`u6jiu5FDd?6B2!V| #JuXYcb;;wE$LfI 9 |r(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((^ 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalCJ_HaJmHsHtHF@F  Heading 3$d@& 6mH sH DA`D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k ( 0No List 4@4 Header  p#4U@4  Hyperlink >*ph>@>  Footnote TextCJaJ@&@!@ Footnote ReferenceH*4 @24 Footer  p#RBR Sprechblasentext1CJOJQJ^JaJB^RB  Normal (Web)dd[$\$0a0 captionlabelB'qB Comment ReferenceCJaJ<<  Comment TextCJaJ@@ Kommentarthema15\.)@.  Page Number*W* Strong5\HH  Balloon TextCJOJQJ^JaJ8O8 apple-style-span@j@ Comment Subject5\PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 4'; 8i>B   4 e  Ǡ  ) Z    $ &&&&TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVVVVVVVVVY 56q`&7$G^l}Ԝ3L * %o6F_tpWiŞٞ@eǟ5Dk{Ҡ"/8@^fpx¡2Sy͢բߢ.5JQPrޤئPzߧ*+qrOy78̜Ԝ      !"#$%&'()*+,-./012456789:;<=>?@ABCDEFGHIJKO_ y n|4K5$*?++.4..P1e14B$C]CEEE|III=LZLLOO@PRSUZZM\__b'e.eMeJgQgvjllsw3ww.{s{}Zqo x2!qz=%,GN#B+Yn& $h  ^ 3z,8;#;ATԒʔXQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ̕XX "Y!!84=@<0(  B S  ?'ElzEz Ez E,z Ez Elz EzE,zElzEzEzE,zElzEzEzE,zElzEzEzE,zElzEzEzEE ED!E"E#E$ED%E&E'E (ED)E*E+E,ED-E{!))jj" ##+3--;;Npp      !%"#$& ''//!)) *29944MUU   !#$%"& 9'*urn:schemas-microsoft-com:office:smarttagsplace=&*urn:schemas-microsoft-com:office:smarttags PlaceName=$*urn:schemas-microsoft-com:office:smarttags PlaceType8"*urn:schemas-microsoft-com:office:smarttagsCity;*urn:schemas-microsoft-com:office:smarttagsaddressB*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsState>*urn:schemas-microsoft-com:office:smarttags PostalCode:*urn:schemas-microsoft-com:office:smarttagsStreet ('&&$'"'"'&&'"''"'&&$'&&$'"'"'"&"9"K"\"^"k"l"s"x333333336666;9\9;;~AAJJ\K]KMMNNNNQQQRR R RRRRySzSoTpT2U3UUUWW,Y-YsZtZ[[\\m]n]^^^^c_d_````obpbc4c6cBcCcJccccddddd`eaeggdjej{k|kllmmzp{prrrrssNtOtttuuuuuvvvvvvvvvvvvv[wwwwwwwwxxzzzz}}+~,~~~Ā"#i”ʔɪ2< ɪ333jtCaaϛ//88YY(VIAe5Ҙ"Ù2TyRԛ ܝ*G ۠)Lҡ.P̪VQc+ "=^>%0TF>@PuE"DAp4'=h){]C;{E1[IH{wIӬQK$N2R N xcYι*aj#Nk-iMwlBx[SxYp7VyTw" hh^h`hH. P^`PhH.. ^`hH... x^`xhH....  ^`hH .....  X@ ^ `XhH ......  ^ `hH.......  8x^`8hH........  `H^``hH.........h^`OJQJo(hHhV^`VOJQJo(hH" $ $ ^$ `OJPJQJ^Jo(-h  ^ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhdd^d`OJQJo(hHh44^4`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhV^`VOJQJo(hH" hpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L. hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH.^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`OJPJQJ^Jo(-^`OJQJ^Jo(hHo  ^ `OJQJo(hH  ^ `OJQJo(hHll^l`OJQJ^Jo(hHo<<^<`OJQJo(hH  ^ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hHh^`OJQJo(hHhV^`VOJQJo(hH" hpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh&&^&`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhf!f!^f!`OJQJ^Jo(hHoh6$6$^6$`OJQJo(hHh''^'`OJQJo(hHh))^)`OJQJ^Jo(hHoh,,^,`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`OJPJQJ^Jo(^`OJQJ^Jo(hHopp^p`OJQJo(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH ^`hH Artikel . ^`hH Abschnitt . P^`PhH() `p`^``phH() P^`PhH) P^`PhH) ^`hH) P^`PhH. 0p0^0`phH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.{]Cx[Sx4'PuE"c+ h)^VQ@ajwIMwl7Vy%0QK2R1[IHxcY;{ENk85A85<'5XPjR28R <'U+GS-6N;\Y\)e>jwkj=p Hp\vXbRX][/NY-jS1EN.InstantFormatr EN.Layout@hV EN.Libraries w<ENInstantFormat><Enabled>0</Enabled><ScanUnformatted>1</ScanUnformatted><ScanChanges>1</ScanChanges></ENInstantFormat>S<ENLayout><Style>APA 5th</Style><LeftDelim>{</LeftDelim><RightDelim>}</RightDelim><FontName>Times New Roman</FontName><FontSize>12</FontSize><ReflistTitle></ReflistTitle><StartingRefnum>1</StartingRefnum><FirstLineIndent>0</FirstLineIndent><HangingIndent>720</HangingIndent><LineSpacing>0</LineSpacing><SpaceAfter>0</SpaceAfter></ENLayout>Y<ENLibraries><Libraries><item>White paper review_Lit.enl</item></Libraries></ENLibraries>@4/`@``L@`8@UnknownlindaG* Times New Roman5Symbol3. * Arial7.  Verdana5. *aTahoma?= * Courier New;WingdingsA BCambria MathB1FF&d?Vi?j!4dϩ 3qHX $P Hp2!xx?Running Head: EFFICACY OF BIOFEEDBACK FOR TENSION TYPE HEADACHEnestoriulinda\               Oh+'0   0< \ h t @Running Head: EFFICACY OF BIOFEEDBACK FOR TENSION TYPE HEADACHE nestoriu Normal.dotmlinda2Microsoft Office Word@F#@ @ԝw@ԝwd?Vi՜.+,D՜.+, hp  h Philipps Universitt Marburg @Running Head: EFFICACY OF BIOFEEDBACK FOR TENSION TYPE HEADACHE@Running Head: EFFICACY OF BIOFEEDBACK FOR TENSION TYPE HEADACHE TitleTitel 8@ _PID_HLINKSA|N'-mailto:yvonne.nestoriuc@staff.uni-marburg.depFmailto:ynestoriuc@partners.orgpFmailto:ynestoriuc@partners.org  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'(*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcefghijkmnopqrszRoot Entry Fw|Data Rk1Table)uWordDocumentUSummaryInformation(dDocumentSummaryInformation8lCompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q